CIBMTR Publication List
Since 1972, use of CIBMTR data and statistical resources have resulted in more than 500 publications in peer-reviewed scientific journals. These publications are organized by year below, and can be searched to help you quickly find the information you need.
Display:
2010
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2010 | The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared to matched controls. | Bishop MM, Lee SJ, Beaumont JL, Andrykowski MA, Rizzo JD, Sobocinski KA, Wingard JR. | Biol Blood Marrow Transplant 16:207-214 |
| 2010 | Hematopoietic stem cell transplantation for Non-hodgkin lymphoma in children and adolescents. | Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang M-J, Davies SM, Eapen M. | Biol Blood Marrow Transplant 16:223-230 |
| 2010 | The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. | Collins NH, Gee AP, Durett AG, Kan F, Zhang M-J, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf D. | Biol Blood Marrow Transplant 16:253-262 |
| 2010 | A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B-cell lymphoma: a report from the CIBMTR. | Lazarus HM, Zhang M-J, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD , Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN. | Biol Blood Marrow Transplant 16:35-45 |
| 2010 | Outcome of transplantation for Myelofibrosis. | Ballen KK, Shrestha S, Sobocinski KA, Zhang M-J, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kröger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Vivek Roy V, Wiernik PH, Horowitz MM, Giralt SA, Arora M. | Biol Blood Marrow Transplant 16:358-367 |
| 2010 | Outcomes of hematological malignancies after unrelated donor hematopoietic-cell transplantation according to place of residence. | Loberiza FR Jr, Lee SJ, Klein JP, Hassebroek A, Dehn JG, Frangoul HA, Hahn T, Hale G, Lazarus HM, LeMaistre CF, Maziarz RT, Rizzo JD, Majhail NS. | Biol Blood Marrow Transplant 16:368-375 |
| 2010 | Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. | Hari PN, Majhail N, Zhang M-J, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes C, Gibson J, Hale G, Holmberg L, Kamble R, Kyle R, Lazarus H, LeMaistre C, Loberiza F, Maiolino A, McCarthy P, Milone G, Omondi N, Reece D, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee S, Rizzo JD, Mehta P. | Biol Blood Marrow Transplant 16:395-402 |
| 2010 | Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network. | Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D. | Biol Blood Marrow Transplant 16:421-429 |
| 2010 | High dose chemotherapy with blood or marrow transplant for Rhabdomyosarcoma: a CIBMTR analysis. | Stiff PJ, Agovi M-A, Antman K, Blaise D, Camitta BM, Cairo MS, Childs RW, Edwards JR, Gale RP, Hale GA, Horowitz MM, Lazarus HM, Arora M. | Biol Blood Marrow Transplant 16:525-532 |
| 2010 | Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. | Kalaycio ME, Kukreja M, Woolfrey AE, Szer J, J Cortes J, Maziarz RT, Bolwell BJ, Buser A, Copelan E, Gale RP, Gupta V, Maharaj D, Marks DI, Pavletic SZ ,Horowitz MM, Arora M. | Biol Blood Marrow Transplant 16:543-547 |
| 2010 | An approach to predicting HCT outcome using HLA-mismatch information mapped on protein structure data. | Hurley CK, Oudshoorn M, Setterholm M,Spellman SR, Petersdorf E, Lee SJ, Gooley T, Malkki M, Horowitz MM. | Biol Blood Marrow Transplant 16:865-866 |
| 2010 | Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. | Litzow M, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, DiPersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini M, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ. | Blood 115:1850-1857 |
| 2010 | Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation. | McDermott DH, Conway SE, Wang T, Ricklefs SM, Agovi M, Porcella SF, Tran HTB, Milford E, Spellman S and Abdi R. | Blood 115:2311-2318 |
| 2010 | The detection of donor directed, HLA-specific alloantibodies in recipients of unrelatead hematopoietic cell transplantation is predictive of graft failure. | Spellman S, Bray R, Rosen-Bronson S, Haagenson M, Klein J, Flesch S, Vierra-Green C, Anasetti C. | Blood 115:2704-2708 |
| 2010 | Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. | Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, Petersdorf E, Hsu KC. | Blood 115:3162-3165 |
| 2010 | Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation. | Nguyen Y, Al-Lehibi A, Gorbe E, Li E, Haagenson M, Wang T, Spellman S, Lee S, Davidson NO. | Blood 115:3625-3631 |
| 2010 | Practice patterns for evaluation, consent and care of related donors and recipients at hematopoietic cell transplant centers in the United States. | O’Donnell PV, Pedersen TL, Confer DL, Rizzo JD, Pulsipher MA, Stroncek D, Leitman S, Anderlini P. | Blood 115:5097-5101 |
| 2010 | The outcome of full-intensity versus reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. | Marks, DI Wang T, Pérez WS, Antin JH, Copelan E, Gale RP, George B, Gupta V, Halter J, Khoury HJ, Klumpp TR, Lazarus HM, Lewis VA, McCarthy P, Rizzieri DA, Sabloff M, Szer J, Tallman MS, Weisdorf D. | Blood 116:366-374 |
| 2010 | Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. | Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang M-J, Horowitz MM, Abhyankar S. | Bone Marrow Transplant 45:1068-1076 |
| 2010 | WMDA Accrediatation and Regulatory Committees, Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products. | Hurley CK, Foeken L, Horowitz M, Lindberg B, McGregor M, Sacchi N. | Bone Marrow Transplant 45:819-824 |
| 2010 | Access to hematopoietic stem cell transplantation: effect of race and gender. | Joshua TV, Rizzo JD, Zhang M-J, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SL, Horowitz MM. | Cancer 116:3469-3476 |
| 2010 | Competing risks. | Klein JP. | In: Comput Stats Vol. 2, pp. 333-339 |
| 2010 | Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndro | McClune BL, Weisdorf DJ, Pedersen TL, Tunes de Silva G, Tallman MS, Sierra J, DiPersio J, Keating A, Gale RP, George B, Gupta V, Hahn T, Isola L, Jagasia M, Lazarus H, Marks D, Maziarz R, Miller A, Waller EK, Bredeson C, Giralt S. | J Clin Oncol 28:1878-1887 |
| 2010 | Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. | Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD. | J Clin Oncol 28:1888-1895 |
| 2010 | Hematopoietic stem cell transplantation: a global perspective. | Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Fernando- Bouzas L, Yoshimi A, Szer J, Lipton J, SchwendenerA, Gratwohl M, Frauendorfer K, Niederwieser D, Horowitz M, Kodera Y; for the Worldwide Network of Blood and Marrow Transplantation. | JAMA 303:1617-1624 |
| 2010 | Effect of graft source on unrelated donor hematopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. | Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang M-J, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE. | Lancet Oncol 11:653-660 |
2009
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2009 | High-resolution typing for unrelated donor transplantation: how far do we go? | Horowitz MM. | Best Pract Res Clin Haematol 22:537-541 |
| 2009 | Methods for equivalence and noninferiority testing. | Tunes da Silva G, Logan BR, Klein JP. | Biol Blood Marrow Transplant 15(1 Suppl):120-127 |
| 2009 | An approach to predicting hsct outcome using hla-mismatch information mapped on protein structure data biology of blood and marrow transplantation. | Oudshoorn M, Setterholm M,Spellman SR, Petersdorf E, Lee SJ, Gooley T, Malkki M, Horowitz MM. | Biol Blood Marrow Transplant 15:1014-1025 |
| 2009 | Unrelated donor reduced-intensity and nonmyeloablative stem cell transplantation for patients with relapsed and refractory Hodgkin lymphoma. | Devetten MP, Hari P, Carreras J, Logan BR, van Besien K, Bredeson CN, Freytes CO, Gale RP, Gibson J, Giralt SA, Goldstein SC, Gupta V, Marks DI, Maziarz RT, Vose JM, Lazarus HM, Anderlini P. | Biol Blood Marrow Transplant 15:109-117 |
| 2009 | The effect of smoking on allogeneic transplant outcomes. | Marks DI, Ballen K, Logan BR, Wang Z, Sobocinski KA, Bacigalupo A, Burns LJ, Gupta V, Ho V, McCarthy PL, Ringden O, Schouten HC, Seftel M, Rizzo JD. | Biol Blood Marrow Transplant 15:1277-1287 |
| 2009 | Impact of pre-transplant Rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma. | Fenske TS, Hari PN, Carreras J, Zhang M-J, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen Y-B, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM. | Biol Blood Marrow Transplant 15:1455-1464 |
| 2009 | Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse. | Weisdorf DJ, Nelson G, Lee SJ, Haagenson M, Spellman S, Antin JH, Bolwell B, Cahn J-Y, Cervantes F, Copelan E, Gale R, Gratwohl A, Khoury HJ, McCarthy P, Marks DI, Szer J, Woolfrey A, Cortes-Franco J, Horowitz MM, Arora M. | Biol Blood Marrow Transplant 15:1475-1478 |
| 2009 | Impending Challenges in the Hematopoietic Stem Cell Transplant Physician Workforce. | Gajewski JL, LeMaistre CF, Silver SM, Lill MC, Selby GB, Horowitz MM, Rizzo JD, Heslop HE, Anasetti C, Maziarz RT. | Biol Blood Marrow Transplant 15:1493-1501 |
| 2009 | Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. | Baker KS, Davies SM, Majhail NS, Hassebroek A, Klein JP, Ballen, KK Bigelow CL, Haydar A, Frangoul HA, Hard CL, Lee SJ, Rizzo JD. | Biol Blood Marrow Transplant 15:1543-1554 |
| 2009 | Defining the intensity of conditioning regimens: working definitions. | Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M. | Biol Blood Marrow Transplant 15:1628-1633 |
| 2009 | Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants. | Davies SM, Wang D, Wang T, Arora M, Ringden O, Anasetti C, Pavletic S, Casper J, MacMillan ML, Sanders J, Wall D, Kernan NA. | Biol Blood Marrow Transplant 15:360–366 |
| 2009 | Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research (CIBMTR). | Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B. | Biol Blood Marrow Transplant 15:367–369 |
| 2009 | Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes. | van Besien K, Carreras J, Bierman PJ, Logan BR, Molina A, King R, Nelson G, Fay JW, Champlin RE, Lazarus HM, Vose JM, Hari PN. | Biol Blood Marrow Transplant 15:554-563 |
| 2009 | Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. | Lazarus HM, Kan F, Tarima S, Champlin RE, Confer D, Frey N, Gee AP, Wagner JE, Horowitz MM, Eapen M. | Biol Blood Marrow Transplant 15:589-596 |
| 2009 | Risk factors affecting outcome of second HLA-matched sibling donor transplantation for graft failure in severe acquired Aplastic anemia. | Horan J, Carreras J, Tarima S, Camitta BM, Gale RP, Hale GA, Hinterberger W, Marsh J, Passweg JR, Walters MC, Mary Eapen M. | Biol Blood Marrow Transplant 15:626-631 |
| 2009 | Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. | Spellman SR, Warden MB, Haagenson MD, Pietz BC, Goulmy E, Warren EH, Wang T, Ellis TM. | Biol Blood Marrow Transplant 15:856-863 |
| 2009 | Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematological disorders: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR). | Gupta V, Tomblyn M, Pedersen TL, Atkins HL, Battiwalla M, Gress RE, Pollack MS, Storek J, Thompson JC, Tiberghien P, Young JA, Ribaud P, Horowitz MM, Keating A. | Biol Blood Marrow Transplant 15:864-871 |
| 2009 | Methodological and logistical considerations to study design and data collection in racial/ethnic minority populations evaluating outcome disparity in hematopoietic cell transplantation. | Loberiza FR, Jr., Lee SJ, Freytes CO, Giralt SA, Van Besien K, Kurian S, Del Ciero P, Toro JJ, Williams LA, Ketelsen SW, Navarro WH, Rizzo JD. | Biol Blood Marrow Transplant 15:903-909 |
| 2009 | HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. | Baxter-Lowe LA, Maiers M, Spellman SR, Haagenson MD, Wang T, Gernandez-Vina M, Marsh SGE, Horowitz M, Hurley CK. | Biol Blood Marrow Transplant 15:971-981 |
| 2009 | Solid cancers after allogeneic hematopoietic cell transplantation. | Rizzo JD, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers MED, Friedman D, Horowitz MM, Wingard JR, Deeg HJ. | Blood 113:1175-1183 |
| 2009 | The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. | Ringdén O, Pavletic S, Anasetti C, Barrett JA, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M. | Blood 113:3110-3118 |
| 2009 | Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. | Pulsipher MA, Chitphakdithai P, Miller J, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson M, Kurian S, Klein JP, Horowitz MM, Confer DL. | Blood 113:3604-3611 |
| 2009 | Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. | Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE | Blood 113:4992-5001 |
| 2009 | Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. | Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le C, Marsh SGE, Guethlein LA, Parham P, Miller JS, Weisdorf DJ. | Blood 113:726-732 |
| 2009 | Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. | Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL. | Blood 114:2606-2616 |
| 2009 | Limited role of MHC class I chain–related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen– matched unrelated donor transplantation. | Anderson E, Grzywacz B, Wang H, Wang T, Haagenson M, Spellman S, Blazar BR, Miller JS, Verneris MR. | Blood 114:4753-4754 |
| 2009 | Etanercept, mycophenolate, denileukin or pentostatin plus corticosteroids for acute graft vs. host disease: a randomized phase II trial from the Blood and Marrow Transplant Clinical Trials Network. | Alousi AM, Weisdorf DJ, Logan BR, Bolanos-Meade J, Carter S, DiFronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE. | Blood 114:511-517 |
| 2009 | Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. | Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK, Shamsi T, Ben Othman T, Sarhan MM, Dennison D, Ibrahim A, Benchekroun S, Chaudhri N, Labar B, Horowitz M, Niederwieser D, Gratwohl A. | Bone Marrow Transplant 43:1-12 |
| 2009 | Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? | Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM. | Bone Marrow Transplant 43:435-446 |
| 2009 | Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation. | Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S. | Br J Haematol 145:816-24 |
| 2009 | Long-term survival and late relapse in 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and non-Hodgkin-lymphoma. | Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang M-J, Rizzo JD. | Br J Haematol 147:129-139 |
| 2009 | Stem cell donation - What advice can be given to the donor? | Pamphilon D, Siddiq S, Brunskill S, Dorée C, Hyde C, Horowitz M, Stanworth S. | Br J Haematol 147:71-76 |
| 2009 | Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management. | Griffith LM, Cowan MJ, Notarangelo LD, Puck JM, Buckley RH, Candotti F, Conley ME, Fleisher TA, Gaspar HB, Kohn DB, Ochs HD, O'Reilly RJ, Rizzo JD, Roifman CM, Small TN, Shearer WT. | J Allergy Clin Immunol 124:1152-1160 |
| 2009 | HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. | Arora M, Weisdorf DJ, Spellman S, Haagenson M, Klein JP, Hurley CK, Selby GB, Antin JH, Kernan NA, Kollman C, Nademanee A, McGlave P, Horowitz MM, Petersdorf E. | J Clin Oncol 27:1637-1643 |
| 2009 | A Mass Redistribution Algorithm for Right-censored and Left-truncated Time to Event Data. | Zhang X, Zhang MJ, Fine JP. | J of Stat Planning and Inference 9:3329-3339 |
| 2009 | Is the International staging system superior to the Durie Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. | Hari P, Zhang M-J, Roy V, Pérez WS, Bashey A, Bik To L, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela-Ojeda J, Weisdorf D, Vesole D. | Leukemia 23:1528-1534 |
| 2009 | Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. | Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S. | Pediatrics 123:1011-1017 |
| 2009 | Allogeneic stem cell transplantation for leukocyte adhesion deficiency. | Qasim W, Cavazzana-Calvo M, Davies EG, Davis J, Duval M, Eames G, Farinha N, Filopovich A, Fischer A, Friedrich W, Genery A, Heilmann C, Landais P, Horwitz ME, Porta F, Sedlacek P, Seger R, Slatter M, Teague L, Eapen M, Veys P. | Pediatrics 123:836-840 |
| 2009 | Regression analysis of mean quality-adjusted survival time based on pseudo-observations. | Tunes da Silva G and Klein JP. | Statistics in Medicine 28(7):1054-1066 |
| 2009 | The HLA Dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. | Holdsworth R, Hurley C, Marsh SGE, Lau M, Noreen H, Kempenich J, Setterholm M, Maiers M. | Tissue Antigens 73 (2) 95-170 |
| 2009 | Characterization of 104 novel alleles at the HAL-A, -B, and DRB1 loci from National Marrow Donor Program volunteer donors. | Lazaro AM, Xiao Y, Regenscheid A, Ng J, Hurley CK, Posch PE. | Tissue Antigens 73: 364-372 |
| 2009 | Evaluating the potential impact of mismatches outside of the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101. | Xiao Y, Lazaro AM, Masaberg C, Haagenson M, Vierra-Green C, Spellman S, Dakshanamurthy S, Ng J, Hurley CK. | Tissue Antigens 73: 595-598 |
| 2009 | TNF, LTA and TGFB1 genotype distributions among acute graft versus host disease (aGVHD) subsets after HLA-matched unrelated hematopoietic stem cell transplantation: a pilot study. | Shah R, Selby ST, Yokley B, Slack RS, Hurley CK, Posch PE. | Tissue Antigens 74:50-56 |
2008
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2008 | State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. | Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL. | Biol Blood Marrow Transplant 14(1):1-6 |
| 2008 | HLA matchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. | Duquesnoy R, Spellman S, Haagenson M, Wang T, Horowitz MM, Oudshoorn M. | Biol Blood Marrow Transplant 14:1064-1071 |
| 2008 | Comparison of twin and autologous transplants for multiple myeloma. | Bashey A, Pérez WS, Zhang M-J, Anderson KC, Ballen K, Berenson JR, Fonseca R, Freytes CO , Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P. | Biol Blood Marrow Transplant 14:1118-1124 |
| 2008 | Comparable outcomes in non-secretory and secretory multiple myeloma after autologous stem cell transplantation. | Kumar S, Pérez WS, Zhang M-J, Ballen K, Bashey A, Bik To L, Bredeson CN, Cairo MS, Elfenbein GJ, Freytes CO, Gale RP, Gibson J, Kyle RA, Lacy MQ, Lazarus HM, McCarthy PL, Milone GA, Moreb JA, Pavlovsky S, Reece DE, Vesole DH, Wiernik PH, Hari P. | Biol Blood Marrow Transplant 14:1134-1140 |
| 2008 | HLA-matched sibling hematopoietic stem cell transplantation for Fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. | Pasquini R, Carreras, J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang M-J, Eapen M, Wagner JE. | Biol Blood Marrow Transplant 14:1141-1147 |
| 2008 | Variation in supportive care practices in hematopoietic cell transplantation. | Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR, Jr, Bevans M, Soiffer RJ, Joffe S. | Biol Blood Marrow Transplant 14:1231-1238 |
| 2008 | Influence of age and histology on outcome in adult non-hodgkin’s lymphoma patients undergoing autologous HCT: a report from the Center for International Blood & Marrow Transplant Research (CIBMTR). | Lazarus HM, Carreras J, Boudreau C, Loberiza FR, Jr, Armitage JO, Bolwell BJ, Freytes CO, Gale RP, Gibson J, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Miller AM, Pavlovsky S, Schouten HC, van Besien K, Vose JM, Rizzo JD. | Biol Blood Marrow Transplant 14:1323-1333 |
| 2008 | Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match. | Dehn J, Arora M, Spellman S, Setterholm M, Horowitz M, Confer D, Weisdorf D. | Biol Blood Marrow Transplant 14:1334-1340 |
| 2008 | HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. | Schlenk RF, Pasquini MC, Pérez WS, Zhang M-J, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn J-Y, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A. | Biol Blood Marrow Transplant 14:187-196 |
| 2008 | Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. | Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN, Burns LJ, Cairo M, Freytes CO, Goldstein SC, Hale GA, Inwards DJ, LeMaistre CF, Maharaj D, Marks DI, Schouten HC, Slavin S, Vose JM, Lazarus HM, van Besien K. | Biol Blood Marrow Transplant 14:236-245 |
| 2008 | Lifetime probabilities of hematopoietic stem cell transplantation in the US: implications for umbilical cord blood storage. | Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. | Biol Blood Marrow Transplant 14:316-322 |
| 2008 | On the probability of using cord blood. | Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM. | Biol Blood Marrow Transplant 14:724-725 |
| 2008 | Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. | Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J. | Biol Blood Marrow Transplant 14:748-758 |
| 2008 | Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant. | Smith SM, van Besien K, Carreras J, Bashey A, Cairo MS, Freytes CO, Gale RP, Hale GA, Hayes-Lattin B, Holmberg LA, Keating A, Maziarz RT, McCarthy PL, Navarro WH, Pavlovsky S, Schouten HC, Seftel M, Wiernik PH, Vose JM, Lazarus HM, Hari P. | Biol Blood Marrow Transplant 14:904-912 |
| 2008 | Outcomes following HCT using Fludarabine, Busulfan and Thymoglobulin: A matched comparison to allogeneic transplants conditioned with Busulfan and Cyclophosphamide. | Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA. | Biol Blood Marrow Transplant 14:993-1003 |
| 2008 | Principles and tools for selection of umbilical cord blood and unrelated adult donor grafts. | Lee SJ, Kamani N, Confer DL. | Biol Blood Marrow Transplant 14 (1):112-119 |
| 2008 | Comparing treatments in the presence of crossing survival curves: An application to bone marrow transplantation. | Logan BR, Klein JP, Zhang MJ. | Biometrics 64:733-740 |
| 2008 | Predicting cumulative incidence probability by direct binomial regression. | Scheike TH, Zhang MJ, Gerds TA. | Biometrika 95:205-220 |
| 2008 | Radiological and nuclear events: contingency planning for hematologist/oncologists. | Weinstock DM, Case Jr. C, Bader JL, Chao NJ, Coleman CN, Hatchett RJ, Weisdorf DJ, Confer DL. | Blood 111 (12): 5440–5445 |
| 2008 | Response: radiologic and nuclear events. | Weinstock DM, Case, Jr. C, Confer DL. | Blood 111 (12): 5758–5759 |
| 2008 | Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia. | Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT. | Blood 112:3500-3507 |
| 2008 | Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. | Marks DI, Pérez WS, He W, Zhang M-J, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowsi AA, Keating A, Klumpp TR, Lazarus HM, Liesveld JL, Maziarz RT, McCarthy PL, Sabloff M, Schiller G, Sierra J, Tallman MS, Waller EK, Wiernik PH, Weisdorf DJ. | Blood 112:426-434 |
| 2008 | Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. | Cutler C, Stevenson K, Kim HT, Richardson P, Ho VT, Linden E, Revta C, Ebert R, Warren D, Choi S, Koreth J, Armand P, Alyea E, Carter S, Horowitz MM, Antin JH, Soiffer R. | Blood 112:4425-4431 |
| 2008 | Allogeneic hematopoietic cell transplantation for metastatic breast cancer. | Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D. | Bone Marrow Transplant 41:537-545 |
| 2008 | Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. | Bishop MR, Logan BR, Gandham S, Bolwell BJ, Cahn J-Y, Lazarus HM, Litzow MR, Marks DI, Wiernik PH, McCarthy PL, Russell JA, Miller C, Sierra J, Milone G, Keating A, Loberiza FR Jr, Giralt SA, Horowitz MM, Weisdorf DJ. | Bone Marrow Transplant 41:635-642 |
| 2008 | Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. | Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Grovas AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M. | Bone Marrow Transplant 41:867-872 |
| 2008 | Unrelated donor hematopoietic cell transplantation for hemaophagocytic lymphohistiocytosis. | Baker KS, Filipovich AH, Gross TG, Grossman WJ, Hale GA, Hayashi RJ, Kamani NR, Kurian S, Kapoor N, Ringdén O, Eapen M. | Bone Marrow Transplant 42:175-180 |
| 2008 | Donor leukocyte infusions to treat hematologic malignancy relapse following allogeneic stem cell transplantation in a pediatric population. | Levine JE, Barrett AJ, Zhang M-J, Pulsipher MA, Bunin N, Fort J, Loberiza FR, Porter D, Giralt S, Drobyski W, Ringdén O, Horowitz MM, Collins R. | Bone Marrow Transplant 42:201-205 |
| 2008 | The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research. | Horowitz MM. | Bone Marrow Transplant 42:S1-S2 |
| 2008 | Outcome of unrelated donor stem cell transplantation for children with severe Aplastic anemia. | Perez-Albuerne ED, Eapen M, Klein JP, Gross TG, Lipton JM, Baker KS, Woolfrey AE, Kamani NR. | Br J Haematol 141:216-223 |
| 2008 | Use of biological assignment in hematopoietic stem cell transplantation clinical trials. | Logan B, Leifer E, Bredeson C, Horowitz M, Ewell M, Carter S, Geller N. | Clin Trials 5:607-616 |
| 2008 | Modeling Cumulative Incidence Function for Competing Risks Data. | Zhang MJ, Zhang X, Scheike TH. | Clinical Pharmacology 1:391-400 |
| 2008 | SAS and R functions to compute pseudo-values for censored data regression. | Klein JP, Gerster M, Andersen, PK, Tarima S, Perme MP. | Comput Methods Programs Biomed 89:289-300 |
| 2008 | Direct regression models for survival parameters basedf on pseudovalues. | Klein JP and Tunes da Silva G. | In: Frontiers of Applied and Computational Mathematics pp. 162-171 |
| 2008 | Mobilization and Transplantation, Old and new cancers after hematopoietic-cell transplantation. | Majhail NS. | In: Hematology 2008 pp. 142-149 |
| 2008 | Limited allelic diversity of stimulatory two-domain killer cell immunoglobulin-like receptors. | Hou L, Steiner NK, Chen M, Belle I, Kubit AL, Ng J, Hurley CK. | Hum Immunol 69 (3): 174–178 |
| 2008 | Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairs. | Williams TM, Winden T, Setterholm M, Vierra-Green CA, Spellman S, Flesch S, Awdeh Z, Baxter-Lowe LA, Begovich AB, Fernandez-Vina M, Hegland J, Hurley CK, Johnson D, Noreen H, Salazar M, Schmeckpeper B, Yunis EJ. | Hum Immunol 69 (4–5): 227–234 |
| 2008 | Promoter variants of KIR2DL5 add to diversity and may impact gene expression. | Mulrooney TJ, Hou L, Steiner NK, Chen M, Belle I, Ng J, Hurley CK. | Immunogenetics 60 (6): 287–294 |
| 2008 | Individual physician practice variation in hematopoietic cell transplantation. | Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR Jr, Soiffer RJ, Eapen M. | J Clin Oncol 26:2162–2170 |
| 2008 | Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. | Bunin NJ, Davies SM, Aplenc R, Camitta BM, DeSantes KB, Goyal RK, Kapoor N, Kernan NA, Rosenthal J, Smith FO, Eapen M. | J Clin Oncol 26:4326-4332 |
| 2008 | Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. | Hahn T, McCarthy PL Jr, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Ringdén O. | J Clin Oncol 26:5728-5734 |
| 2008 | Comparing failure probabilities in the presence of competing risks. | Bajorunaite R and Klein JP. | J of Statistical Computation and Simulation 78(10):951-66 |
| 2008 | Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children’s Oncology Group and the Center for International Blood and Marrow Transplant Research. | Eapen M, Zhang MJ, Devidas M, Raetz E, Barredo JC, Ritchey AK, Godder K, Grupp S, Lewis VA, Malloy K, Carroll WL, Davies SM, Camitta BM. | Leukemia 22:281-286 |
| 2008 | Guest editor introduction to issue on transplant statistics. | Klein, JP and Zhang MJ. | Lifetime Data Anal 14:377-378 |
| 2008 | Principles and analysis of hematopoietic cell transplantation: the physician’s eye-view. | Eapen M, Rocha V. | Lifetime Data Anal 14:379-388 |
| 2008 | Analyzing center specific outcomes in hematopoietic cell transplantation. | Logan BR, Nelson GO, Klein JP. | Lifetime Data Anal 14:389-404 |
| 2008 | Inference for current leukemia free survival. | Liu L, Logan B, Klein JP. | Lifetime Data Anal 14:432-446 |
| 2008 | Flexible competing risks regression modelling and goodness-of-fit. | Scheike TH, Zhang M-J. | Lifetime Data Anal 14:464-483 |
| 2008 | Use of cost-effectiveness analysis to determine inventory size for a national cord blood bank. | Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM. | Med Decis Making 28:243-253 |
| 2008 | Summarizing Differences in Cumulative Incidence Functions. | Zhang MJ, Fine J. | Statistics in Medicine 27:4939–4949 |
| 2008 | Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population. | Belle I, Hou L, Chen M, Steiner NK, Ng J, Hurley CK. | Tissue Antigens 71 (5): 434–439 |
2007
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2007 | BMT CTN State of the Science Symposium 2007. | Ferrara JLM, Anasetti C, Stadtmauer E, Antin J, Wingard J, Lee S, Levine J, Schultz K, Appelbaum F, Negrin R, Giralt S, Bredeson C, Heslop H, Horowitz M. | Biol Blood Marrow Transplant 13:1268-1285 |
| 2007 | Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. | Eapen M, Logan B, Confer D, Haagenson M, Wagner JE, Weisdorf, Wingard JR, Rowley S, Stroncek D, Leitman S, Gee A, Horowitz MM, Anasetti C. | Biol Blood Marrow Transplant 13:1461-1468 |
| 2007 | Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions. | Weisdorf D, Carter S, Confer D, Ferrara J, Horowitz M. | Biol Blood Marrow Transplant 13:257-262 |
| 2007 | Hematopoietic progenitor cell transplantation in 2007: new challenges and new opportunities for the Center for International Blood and Marrow Transplant Research. | Giralt S. | Biol Blood Marrow Transplant 13:263-264 |
| 2007 | Utility of single versus tandem autotransplants for advanced testes/germ cell cancer. A Center for International Blood & Marrow Transplant Research (CIBMTR) analysis. | Lazarus HM, Stiff PJ, Carreras J, Logan BR, Akard L, Bolwell BJ, Childs RW, Gale RP, Klein JP, Lill MC, Pérez WS, Stadtmauer EA, Rizzo JD. | Biol Blood Marrow Transplant 13:778-789 |
| 2007 | Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: Long-term follow-up of the first 285 reported to the National Marrow Donor Program. | Giralt S, Logan B, Rizzo JD, Zhang M-J, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller E, Barker J, Pavletic S, Weisdorf D. | Biol Blood Marrow Transplant 13:844-852 |
| 2007 | Mapping MHC-resident transplantation determinants. | Malkki M, Gooley T, Horowitz M, Absi L, Christiansen CT, Cornelissen JJ, Dormoy A, Dubois V, Gagne K, Gluckman E, Haagenson M, Oudshoorn M, Spellman S, Petersdorf E, for the International Histocompatibility Working Group in Transplantation. | Biol Blood Marrow Transplant 13:986-995 |
| 2007 | Hematopoietic cell transplantation in acute promyelocytic leukemia: A comprehensive review. | Kharfan-Dabaja MA, Abou Mourad YR, Fernandez HF, Pasquini MC, Santos ES. | Biol Blood Marrow Transplant 13:997-1004 |
| 2007 | Optimal donor selection: Beyond HLA. | Confer DL, Miller JP. | Biol Blood Marrow Transplant 13 (1) 83-86 |
| 2007 | Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. | Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD. | Blood 109:2256-2262 |
| 2007 | HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplant. | Wade JA, Hurley CK, Takemoto SK, Thompson J, Davies SM, Fuller TC, Rodey G, Confer DL, Noreen H, Haagenson M, Kan F, Klein J, Eapen M, Spellman S, Kollman C. | Blood 109:4064-4070 |
| 2007 | Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. | Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM. | Blood 109:4582-4585 |
| 2007 | Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. | Miller JS, Cooley S, Parham P, Farag S, Verneris M, McQueen K, Guethlein LA, Trachtenberg E, Haagenson M, Horowitz M, Klein JP, Weisdorf D. | Blood 109:5058-5061 |
| 2007 | Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. | Schrezenmeier H, Passweg JR, Marsh JCW, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AVMB, Socie G, Eapen M. | Blood 110:1397-1400 |
| 2007 | Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. | Tallman MS, Dewald GW, Gandham S, Logan BR, Keating A, Lazarus HM, Litzow MR, Mehta J, Pedersen T, Pérez WS, Rowe JM, Wetzler M, Weisdorf DJ. | Blood 110:409-417 |
| 2007 | The importance of HLA-DPB1 in unrelated donor haematopoietic cell transplantation. | Shaw BE, Gooley TA, Malkki M, Madrigal JA, Begovich AB, Horowitz MM, Gratwohl A, Ringdén O. Marsh SGE, Petersdorf EW. | Blood 110:4560-4566 |
| 2007 | High resolution donor recipient HLA matching contributes to the success of unrelated donor marrow transplantation. | Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C. | Blood 110:4576-4583 |
| 2007 | World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. | Bochtler W, Maiers M, Oudshoorn M, Marsh SGE, Raffoux C, Mueller C, Hurley C. | Bone Marrow Transplant 39, 737-741 |
| 2007 | Hematopoietic cell transplantation for Chediak-Higashi syndrome. | Eapen M, DeLaat CA, Baker KS, Cairo MS, Cowan MJ, Kurtzberg J, Steward CG, Veys PA, Filipovich AH. | Bone Marrow Transplant 39:411-415 |
| 2007 | Interleukin-1 alpha Genotype and Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia. | Mehta PA, Eapen M, Klein JP, Gandham S, Elliott J, Zamzow T, Combs M, Aplenc R, MacMillan ML,Weisdorf DJ, Petersdorf E, Davies SM. | Br J Haematol 137:152-157 |
| 2007 | Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia. | Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL, Sobocinski KA, Horowitz MM, on behalf of the Chronic Leukemia Working Committee of the Center. | Br J Haematol 137:461-467 |
| 2007 | Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. | Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA. Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A. | Br J Haematol 137:479-485 |
| 2007 | A SAS Macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. | Zhang X, Loberiza, Jr. FR, Klein JP, Zhang MJ. | Comput Methods Programs Biomed 88:95-101 |
| 2007 | Two sample tests of the equality of two cumulative incidence functions. | Bajorunaite R, Klein JP. | Comput Stat Data Analysis 51:4269-4281 |
| 2007 | Survival Analysis. | Klein JP, Zhang MJ. | In: Handbook of Statistics Volume 27 Epidemiology and Medical Statistics. Volume 27, pp. 281-320 |
| 2007 | Are there circumstances in which phase 2 study results should be practice-changing? | Tomblyn MR, Rizzo JD. | Hematol 2007:489-492 |
| 2007 | A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. | Hurley CK, Fernandez-Vina M, Hildebrand WH, Noreen HJ, Trachtenberg E, Williams TM, Baxter-Lowe LA, Begovich AB, Petersdorf E, Selvakumar A, Stastny P, Hegland J, Hartzman RJ, Carston M, Gandham S, Kollman C, Nelson G, Spellman S, Setterholm M. | Hum Immunol 68 (1) 30-40 |
| 2007 | Estimation of HLA-A, -B, -DRB1 haplotype frequencies utilizing mixed resolution data from a national registry with selective retyping of volunteers. | Kollman C, Maiers M, Gragert L, Muller C, Setterholm M, Oudshoorn M, Hurley CK. | Hum Immunol 68 (12): 950–958 |
| 2007 | Comprehensive approach to high-resolution KIR typing. | Lebedeva TV, Ohashi M, Zannelli G, Cullen R, Yu N. | Hum Immunol 68 (9): 789–796 |
| 2007 | Common and well-documented HLA alleles: report of the Ad-Hoc Committee of the American Society for Histocompatiblity and Immunogenetics. | Cano P, Klitz W, Mack SJ, Maiers M, Marsh SGE, Noreen H, Reed EF, Senitzer D, Setterholm M, Smith A, Fernandez-Vina M. | Hum Immunol 68:392-417 |
| 2007 | High resolution HLA alleles and haplotypes in the US population. | Maiers M, Gragert L, Klitz W. | Hum Immunol 68:779-788 |
| 2007 | Corrigendum to “High-resolution HLA alleles and haplotypes in the United States population”. | Maiers M, Gragert L, Klitz W. | Hum Immunol 68:779–788 |
| 2007 | Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3. | Luo L, Du Z, Sharma SK, Cullen R, Spellman S, Reed EF, Rajalingam R. | Immunogenetics 59 (10): 779–792 |
| 2007 | The late effects of cancer and hematopoietic cell transplantation on spouses or partners compared with survivors and survivor-matched controls. | Bishop MM, Beaumont JL, Hahn EA, Cella D, Andrykowski MA, Brady MJ, Horowitz MM, Sobocinski KA, Rizzo JD, Wingard JR. | J Clin Oncol 25:1403-1411 |
| 2007 | Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. | Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavaou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE. | Lancet 369:1947-1954 |
| 2007 | Genetically-identical twin transplantation for chronic lymphocytic leukemia. | Pavletic SZ, Zhou G, Sobocinski KA, Marti G, Doney K, DiPersio J, Feremans W, Foroni L, Goodman S, Prentice G, LeMaistre C, Bandini G, Ferrant A, Jacobsen N, Khouri I, Gale RP, Wiestner A, Giralt S, Montserrat E, Chan WC, Bredeson C. | Leukemia 21:2452-2455 |
| 2007 | Asymptotic theory for the Cox semi-Markov illness-death model. | Shu Y, Klein JP, Zhang MJ. | Lifetime Data Anal 13:91-117 |
| 2007 | Direct modeling of regression effects for transition probabilities in multistate models. | Scheike TH and Zhang MJ. | Scand J Stat 34:17-32 |
| 2007 | Regression analysis for multistate models based on a pseudo-value approach, with applications to bone marrow transplantation studies. | Andersen PK, Klein JP. | Scand J Stat 34:3-16 |
| 2007 | Analyzing survival curves at a fixed point in time. | Klein JP, Logan B, Harhoff M, Andersen PK. | Stat Med 26:4505-4519 |
| 2007 | Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. | Cogle CR, Theise ND, Fu DT, Ucar D, Lee S, Guthrie SM, Onergan J, Rybka W, Krause DS, Scott EW. | Stem Cells 25:1881-1887 |
| 2007 | A community standard XML message format for sequencing-based typing data. | Maiers M. | Tissue Antigens 69 (1): 69–71 |
| 2007 | Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. | Petersdorf EW, Gooley T, Malkki M, Horowitz M, for The International Histocompatibility Working Group in Hematopoietic Cell Transplantation (2007). | Tissue Antigens 69:25–30 |
| 2007 | KIR2DL1 allelic diversity: four new alleles characterized in a bone marrow transplant population and three families. | Hou LH, Steiner NK, Chen M, Belle I, Ng J, Hurley CK. | Tissue Antigens 69:250–254 |
| 2007 | MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation. | Malkki M, Gooley T, Horowitz M, Petersdorf EW, on behalf of the IHWG HCT Component (2007). | Tissue Antigens 69:46–49 |
| 2007 | Immune response gene polymorphisms in unrelated donor hematopoietic cell transplantation. | Malkki M, Gooley T, Dubois V, Horowitz M, Petersdorf EW. | Tissue Antigens 69:50–53 |
| 2007 | Allelic diversity in KIR2DL4 in a bone marrow transplant population: description of three novel alleles. | Shulse C, Steiner NK, Hurley CK. | Tissue Antigens 70:157-159 |
| 2007 | KIR3DL2: diversity in a hematopoietic stem cell transplant population. | Gedil MA, Steiner NK, Hurley CK. | Tissue Antigens 70:228-232 |
| 2007 | Seventeen novel alleles add to the already extensive KIR3DL3 diversity. | Hou L, Chen M, Steiner NK, Belle I, Turino C, Ng J, Hurley CK. | Tissue Antigens 70:449-454 |
2006
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2006 | Advances in HLA: Practical implications for selecting adult donors and cord blood units. | Hurley CK, Wagner JE, Setterholm M, Confer D. | Biol Blood Marrow Transplant 12 (1): 28–33 |
| 2006 | Preparing for the unthinkable: Emergency preparedness for the hematopoietic cell transplant program. | Wingard JR, Leahigh AK, Confer D, Edwards J, Billups RL, van den Brink M, Keating A. | Biol Blood Marrow Transplant 12: 1229-1238 |
| 2006 | Acute radiation injury: Contingency planning for triage, supportive care, and transplantation. | Weisdorf D, Chao N, Waselenko JK, Dainiak N, Armitage JO, McNiece I, Confer D. | Biol Blood Marrow Transplant 12: 672-682 |
| 2006 | Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. | Logan BR, Zhang MJ, Klein JP. | Biol Blood Marrow Transplant 12:107-112 |
| 2006 | Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Bone Marrow Transplant Group, Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. | Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JLM, Socié G. | Biol Blood Marrow Transplant 12:138-151 |
| 2006 | Pretransplant consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. | Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander A, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM. | Biol Blood Marrow Transplant 12:204-216 |
| 2006 | A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. | Marks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, Trigg ME, Zhang M-J, Horowitz MM. | Biol Blood Marrow Transplant 12:438-453 |
| 2006 | Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. | Navarro WH, Loberiza FR Jr, Bajorunaite R, Armitage JO, Ballen K, Bashey A, Bredeson CN, Freytes CO, Gibson J, Hale GA, Horowitz MM, Lazarus HM, LeMaistre CF, Lister J, Marks D, Martino R, Maziarz RT, Pavlovsky S, Schiller G, Schouten HC, Stadtmauer E, van Besien K, Vose JM, Rizzo JD. | Biol Blood Marrow Transplant 12:541-551 |
| 2006 | Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. | Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL. | Biol Blood Marrow Transplant 12:758-769 |
| 2006 | Autologous or Allogeneic Stem Cell Transplantation in Patients with Waldenstrom’s Macroglobulinemia. | Anagnostopoulos A, Hari PN, Pérez WS, Ballen K, Bashey A, Bredeson CN, Freytes CO, Gale RP, Gertz MA, Gibson J, Goldschmidt H, Lazarus HM, McCarthy PL, Reece DE, Vesole DH, Giralt SA. | Biol Blood Marrow Transplant 12:845-854 |
| 2006 | The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: A report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Group and the Dutch Registry. | Farag SS, Bacigalupo A, Eapen M, Hurley CK, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Matlack M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Horowitz MM, Weisdorf D, Davies SM, for the KIR Study Group, Center for International Blood and Marrow Transplantation Research. | Biol Blood Marrow Transplant 12:876-884 |
| 2006 | Impact of posttransplant G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. | Khoury HJ, Loberiza FR, Jr, Ringdén O, Barrett AJ, Bolwell BJ, Cahn J-Y, Champlin RE, Gale RP, Hale GA, Urbano-Ispizua A, Martino R, McCarthy PL, Tiberghien P, Verdonck LF, Horowitz MM. | Blood 107:1712-1716 |
| 2006 | 131I-Anti-CD45 antibody plus Busulfan and Cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. | Pagel JM , Appelbaum FR, Eary JF, Rajendran J, Fisher DR, Gooley T, Ruffner K, Nemecek E, Sickle E, Durack L, Carreras J, Horowitz MH, Press OW, Gopal AK, Martin PJ, Irwin D. Bernstein ID, Matthews DC. | Blood 107:2184-2191 |
| 2006 | Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children’s Oncology Group and the Center for International Blood and Marrow Transplant Research. | Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM, for the Children’s Oncology Group and the Center for International Blood and Marrow Transplant Research. | Blood 107:4961-4967 |
| 2006 | Long-term outcome of patients transplanted with mobilized blood or bone marrow: A report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant. | Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE. | Blood 108:4288-4290 |
| 2006 | Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: A preliminary assessment. | Simon W, Segel GB, Lichtman MA. | Blood Cells Mol Dis 37:116-124 |
| 2006 | Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: Joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. | Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, Davies SM, Ferrara JLM, Socié G. | Bone Marrow Transplant 37:249-261 |
| 2006 | Bone marrow transplants from mismatched related and unrelated donors for severe Aplastic Anemia. | Passweg JR, Perez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh, J, Pasquini R, Schrezenmeier H, Socie G, Zhang MJ, Bredeson C, Horowitz MM. | Bone Marrow Transplant 37:641-649 |
| 2006 | Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukemia (AML): a retrospective comparison from the National Marrow Donor Program, The International Bone Marrow Transplant Registry and The Autologous Blood and Marrow Transplant Registry. | Lazarus HM, Perez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Rizzo JD, Spitzer TR, Weisdorf DJ, Zhang M-J, Horowitz MM. | Br J Haematol 132:755-769 |
| 2006 | Survival analysis based on the proportional hazards model and survey data. | Boudreau C, Lawless JF. | Can J Stat 34:203-216 |
| 2006 | Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. | Eapen M, Rubinstein P, Zhang M-J, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE. | J Clin Oncol 24:145-151 |
| 2006 | High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: A Center for International Blood and Marrow Transplant Research study. | Vesole DH, Pérez WS, Akasheh M, Boudreau C, Reece DE, Bredeson CN, Bashey A, Brunvand MW, Dispenzieri A, Freytes CO, Gale RP, Gibson J, Giralt SA, Holland HK, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Schiller G, Siegel D, Wiernik PH. | Mayo Clinic Proc 81:880-888 |
| 2006 | Modeling competing risks in cancer studies. | Klein JP. | Stat Med 25:1015-1034 |
| 2006 | Modeling the subdistribution of a competing risk. | Sun LQ, Liu JX, Sun JG, Zhang MJ. | Statistica Sinica 16:1367-1385 |
| 2006 | Haplotype associations of 90 rare alleles from the National Marrow Donor Program. | Kempenich JH, Setterholm M, Maiers M. | Tissue Antigens 67: 284–289 |
2005
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2005 | Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy? | Rizzo JD. | Best Pract Res Clin Haematol 18:439-448 |
| 2005 | ABO blood group barrier in allogeneic bone marrow transplantation revisited. | Seebach JD, Stussi G, Passweg JR, Loberiza FR Jr, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein JG, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ. | Biol Blood Marrow Transplant 11:1006-1013 |
| 2005 | Bone marrow transplantation for Diamond-Blackfan anemia. | Roy V, Pérez WS, Marsh JCW, Pasquini M, Pasquini R, Ball SE, Camitta BM, Eapen M, Gale RP, Gross TG, Hale GA, Horan JT, Lipton JM, Mustafa MM, Niemeyer CM, Orchard PJ, Bredeson CN. | Biol Blood Marrow Transplant 11:600-608 |
| 2005 | Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. | Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW, Gratwohl A, van Laar JM, Mayes MD, Martin R, McSweeney PA, Muraro PA, Openshaw H, Saccardi R, Sandmaier BM, Forman SJ, Nash RA, on behalf of the workshop participants. | Biol Blood Marrow Transplant 11:862-870 |
| 2005 | Differences in characteristics of United States hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities. | Schwake CJ, Eapen M, Lee SJ, Freytes CO, Giralt SA, Navarro WH, Rizzo JD, van Besien K, Loberiza FR Jr. | Biol Blood Marrow Transplant 11:988-998 |
| 2005 | Simulation based goodness of fit tests for a copula based on bivariate right-censored data. | Andersen PK, Ekstrøm CT, Klein JP, Shu Y, Zhang MJ. | Biomed J 47:815-824 |
| 2005 | Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function. | Klein JP, Andersen PKA. | Biometrics 61:223-229 |
| 2005 | Additive hazards Markov regression models illustrated with bone marrow transplant data. | Shu Y, Klein JP. | Biometrika 92:283-302 |
| 2005 | Comparison of graft-vs-host disease and survival after HLA-identical sibling bone marrow transplantation in different ethnic populations. | Oh H, Loberiza FR Jr, Zhang M, Ringdén O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin J, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey PJ, Kolb HJ, Litzow MR, McCarthy PL, Neudorf SM, Serna DS, Socié G, Tiberghien P, Barrett AJ. | Blood 105:1408-1416 |
| 2005 | Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. | Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD. | Blood 105:2979-2987 |
| 2005 | Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: An international case-control study. | Curtis RE, Metayer C, Rizzo JD, Socié G, Sobocinski KA, Flowers MED, Travis WD, Travis LB, Horowitz MM, Deeg HJ. | Blood 105:3802-3811 |
| 2005 | Prospective evaluation of two acute graft–versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI) and International Bone Marrow Transplant Registry (IBMTR) prospective study. | Cahn JY, Klein JP, Lee SJ, Milpied N, Blaise D, Antin JH, Leblond V, Ifrah N, Jouet JP, Loberiza F, Ringden O, Barrett AJ, Horowitz MM, Socié G. | Blood 106:1495-1500 |
| 2005 | KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. | Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, Miller JS. | Blood 106:4370-4376 |
| 2005 | Outcome of unrelated transplants in patients with multiple myeloma. | Ballen K, King R, Carston M, Kollman C, Nelson G, Lim S, Reece D, Giralt S, Vesole D. | Bone Marrow Transplant 2005 35 (7): 675–681 |
| 2005 | Risk factors from bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. | Santo Thomas LH, Loberiza FR Jr, Klein JP, Layde PM, Lipchik RJ, Rizzo JD, Bredeson CN, Horowitz MM. | Chest 128:153-161 |
| 2005 | Optimal two-stage randomized phase II clinical trials. | Logan BR. | Clin Trials 2:5-12 |
| 2005 | Survival analysis, software | Klein JP and Zhang MJ. | In: Encyclopedia of Biostatistics, volume 2 pp. 5377-5382 |
| 2005 | The HLA dictionary 2004: a summary of HLA-A,-B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. | Schreuder GMT, Hurley CK, Marsh SGE, Lau M, Fernández-Viña M, Noreen HJ, Setterholm M, Maiers M. | European Journal of Immunogenetics 32: 19-69 |
| 2005 | Transfusion Medicine (with AABB), Evaluation of Hematopoietic Stem Cell Donors. | Horowitz MM, Confer DL. | In: Hematology 2005, American Society of Hematology, Education Program Book, Atlanta, GA, December 10-13, 2005. pp. 469-475 |
| 2005 | The HLA dictionary 2004: a summary of HLA-A,-B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. | Schreuder GMT, Hurley CK, Marsh SGE, Lau M, Fernández-Viña M, Noreen HJ, Setterholm M, Maiers M. | Hum Immunol 66 (2); 170–210 |
| 2005 | Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant Research. | Pavletic SZ, Khouri IF, Haagenson M, King RJ, Bierman PJ, Bishop MR, Carston M, Giralt S, Molina A, Copelan EA, Ringdén O, Roy V, Ballen K, Adkins DR, McCarthy P, Weisdorf D, Montserrat E, Anasetti C. | J Clin Oncol 23:5788–5794 |
| 2005 | Long-term health-related quality of life, growth, and spiritual well-being following hematopoietic stem cell transplantation. | Andrykowski MA, Bishop M, Hahn EA, Cella D, Beaumont JL, Brady M, Horowitz M, Sobocinski K, Rizzo JD, Wingard JR. | J Clin Oncol 23:599-608 |
| 2005 | Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem cell transplantation in the United States. | Baker KS, Loberiza FR Jr, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ. | J Clin Oncol 23:7032-7042 |
| 2005 | Immune therapy of chronic myelogenous leukaemia. | Gale RP, Horowitz MM, Talpaz M, Scheinberg DA, Molldrem J, Li Z, Baccarani M, Goldman JM, Tura S. | Leuk Res 29:583-586 |
| 2005 | A random effect model for multistate survival analysis with application to bone marrow transplantation. | Bhattacharyya M, Klein JP. | Math Biosci 194:37-48 |
| 2005 | A note on testing in Aalen’s additive hazards regression model. | Bhattacharyya M, Klein JP. | Stat Med 24:2235-2240 |
| 2005 | Pairwise multiple comparison adjustment in survival analysis. | Logan BR, Wang H, Zhang MJ. | Stat Med 24:2509-2523 |
| 2005 | The HLA dictionary 2004: a summary of HLA-A,-B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. | Schreuder GMT, Hurley CK, Marsh SGE, Lau M, Fernández-Viña M, Noreen HJ, Setterholm M, Maiers M. | Tissue Antigens 65; 1 – 55 |
| 2005 | Emerging new alleles suggest high diversity of HLA-C locus. | Lebedeva TV, Ohashi M, Huang A, Vasconcellos S, Flesch S, Yu N. | Tissue Antigens 65; 101–106 |
| 2005 | The recombinant HLA-B*5518 allele supports the evidence of conserved haplotype association of rare alleles. | Lebedeva TV, Huang A, Ohashi M, Sibilia P, Alosco SM, Kempenich J, Yu N. | Tissue Antigens 66 (2): 156-159 |
| 2005 | Ethnic differences in donation-related characteristics among potential hematopoietic stem cell donors. | Switzer GE, Dew MA, Harrington DJ, Crowley-Matoka M, Myaskovsky L, Abress L, Confer DL. | Transplantation 80: 890-896 |
2004
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2004 | Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. | Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, Lowry P, Armitage JO, Dainiak N. | Annals of Internal Medicine 140(12):1037-51 |
| 2004 | Considerations when designing a clinical trial of hematopoietic stem cell transplantation for autoimmune disease. | Bredeson CN, Pavletic SZ. | Best Pract Res Clin Haematol 17:327-343 |
| 2004 | Autologous transplantation for diffuse aggressive non-Hodgkin’s lymphoma in first relapse or second remission. | Vose JM, Rizzo JD, Wu JT, Armitage JO, Bashey A, Burns LJ, Christiansen NP, Freytes CO, Gale RP, Gibson J, Giralt S, Herzig RH, LeMaistre CF, McCarthy PL, Nimer SD, Petersen FB, Schenkein DP, Wiernik PH, Wiley JM, Loberiza FR, Lazarus HM, van Besien K, Horowitz MM. | Biol Blood Marrow Transplant 10:116-127 |
| 2004 | Impact of HLA class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome. | Flomenberg N, Weisdorf D, Baxter-Lowe LA, Confer D, Fernández-Viña M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E. | Blood 104: 1923-1930 |
| 2004 | Physicians' attitudes about quality of life issues in hematopoietic stem cell transplantation. | Lee SJ, Joffe S, Kim HT, Socie G, Gilman A, Wingard JR, Horowitz MM, Cella D, Syrjala KL. | Blood 104:2194-2200 |
| 2004 | Myeloablative allogeneic hematopoietic stem cell transplantation in patients who relapse after autologous stem cell transplantation for lymphoma: A report of the International Bone Marrow Transplant Registry. | Freytes CO, Loberiza FR Jr, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna D, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K. | Blood 104:3797-3803 |
| 2004 | A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low risk myelodysplasia is associated with improved outcome. | Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Perez WS, Anasetti C, Bolwell BJ, Cairo MS, Gale RP, Klein JP, Lazarus HM, Liesveld JL, McCarthy PL, Milone GA, Rizzo JD, Schultz KR, Trigg ME, Keating A, Weisdorf DJ, Antin JH, Horowitz MM. | Blood 104:579-585 |
| 2004 | Donor commitment and patient needs. | Bakken R, van Walraven AM, Egeland T. | Bone Marrow Transplant 33: 225-230 |
| 2004 | Hematopoietic stem cell donor registry strategies for assigning search determinants and matching relationships. | Hurley CK, Setterholm M, Lau M, Pollack MS, Noreen H, Howard A, Fernandez-Vina M, Kukuruga D, Mueller CH, Venance M, Wade JA, Oudshoorn M, Raffoux C, Enczmann J, Wernet P, Maiers M. | Bone Marrow Transplant 33: 443-450 |
| 2004 | Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. | Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringden O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, De Lima M. | Bone Marrow Transplant 34:721-727 |
| 2004 | Validation and extension of the EBMT risk score for patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplants. | Passweg JR, Walker I, Sobocinski KA, Rio B, Litzow MR, Carreras E, Szydlo R, Bolwell BJ, Ilhan O, Seiter K, Maharaj D, Pasquini R, Carabasi MH, Kolb HJ, Gale RP, Schouten HC, Cornelissen JJ, Goldman J, Gratwohl A, Montserrat E, Klein JP, Horowitz MM, Giralt S, for the Chronic Leukemia Working Committee of the International Bone Marrow Transplant Registry (IBMTR). | Br J Haematol 125:613-620 |
| 2004 | Center for International Blood and Marrow Transplant Research. | Horowitz MM. | In: Cellular Therapy, A Physician’s Handbook pp. 132-137 |
| 2004 | Statistical analysis in hematopoietic stem cell transplantation. | Klein JP. | In: Clinical Bone Marrow and Blood Stem Cell Transplantation, Third Edition pp. 1695-1702 |
| 2004 | Graft-versus-leukemia effects of bone marrow transplantation. | Bredeson CN, Horowitz MM, Truitt RL. | In: Clinical Bone Marrow and Blood Stem Cell Transplantation, Third Edition pp. 291-310 |
| 2004 | Identical twin hematopoietic stem cell transplantation. | Butturini A, Horowitz MM, Gale RP. | In: Clinical Bone Marrow and Blood Stem Cell Transplantation, Third Edition pp. 773-779 |
| 2004 | Introduction to the Statistical Packages of BMDP, SAS, S-PLUS, SPSS and Stata. | Klein JP and Zhang MJ. | In: Encyclopedia of Biostatistics |
| 2004 | Inference for competing risks. | Klein JP, Bajorunaite R. | In: Handbook of Statistics, Vol. 23 291-311 |
| 2004 | Discretizing a continuous covariate in survival studies. | Klein JP, Wu JT. | In: Handbook of Statistics,Vol. 23 27-42 |
| 2004 | First International Symposium on Osteopetrosis: Biology and therapy. | Eapen M (Discussant). | J Bone Miner Res 19:1356-1375 |
| 2004 | Autologous hematopoietic stem cell transplantation for children with acute myelogenous leukaemia in first or second complete remission-A prognostic factor analysis. | Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH, Sandler ES, Yeager AM, Edwards JR, Horowitz MM. | J Clin Oncol 22:3798-3804 |
| 2004 | Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: The Histocompatibility Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. | Eapen M, Horowitz MM, Klein JP, Champlin RE, Loberiza FR Jr, Ringden O, Wagner JE. | J Clin Oncol 22:4872-4880 |
| 2004 | Autologous haemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR. | Snowden JA, Passweg J, Moore JJ, Miliken S, Cannell P, van Laar JM, Verburg R, Szer J, Taylor K, Joske D, Rule S, Bingham S, Emery P, Burt R, Lowenthal RM, Durez P, McKendry R, Pavletic S, Espigado I, Jantunen E, Kashyap A, Rabusin M, Brooks P, Bredeson C, Tyndall A. | J Rheum 31:482-488 |
| 2004 | Regression Analysis of Restricted Mean Survival Time Based on Pseudo-Observations. | Andersen PK, Hansen MA, Klein, JP. | Lifetime Data Anal 10:335-350 |
| 2004 | Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. | Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM. | N Engl J Med 351:2265-2275 |
| 2004 | Uses and growth of hematopoietic cell transplantation. | Horowitz MM. | In: Thomas’ Hematopoietic Cell Transplantation, Third Edition. pp. 9-15 |
| 2004 | Attrition of potential bone marrow donors at two key decision points leading to donation. | Switzer GE, Dew MA, Goycoolea JM, Myaskovsky L, Abress L, Confer DL. | Transplantation 77: 1529-1534 |
| 2004 | The association of donor center characteristics with attrition from the National Marrow Donor Registry. | Myaskovsky L, Switzer GE, Dew MA, Goycoolea JM, Confer DL, Abress L. | Transplantation 77: 874-880 |
| 2004 | Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. | Kollman C, Abella E, Baitty R, Beatty P, Chakraborty R, Christiansen C, Hartzman RJ, Hurley CK, Milford E, Nyman J, Smith T, Switzer G, Wada R, Setterholm M. | Transplantation 78 (1): 89-95 |
2003
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2003 | Access to stem cell transplantation: do women fare as well as men? | Mehta P, Pollock BH, Nugent M, Horowitz M, Wingard JR. | Am J Hematol 72:99-102 |
| 2003 | National Marrow Donor Program HLA matching guidelines for unrelated marrow transplants. | Hurley C, Baxter-Lowe LA, Davies S, Logan B, Karanes C, Anasetti C, Weisdorf D, Confer D. | Biol Blood Marrow Transplant 9: 610-615 |
| 2003 | Optimistic expectations and survival after hematopoietic stem cell transplantation. | Lee SJ, Loberiza FR, Rizzo JD, Soiffer RJ, Antin JH, Weeks JC. | Biol Blood Marrow Transplant 9:389-396 |
| 2003 | Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. | Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz MM, DiPersio JF. | Biol Blood Marrow Transplant 98:714-721 |
| 2003 | Extensions and applications of the Cox-Aalen survival model. | Scheike TH, Zhang MJ. | Biometrics 59:1038-1047 |
| 2003 | Generalized linear models for correlated pseudo-observations with applications to multi-state models. | Andersen PK, Klein JP, Rosthoj S. | Biometrika 90:15-27 |
| 2003 | Myelodysplastic syndrome and leukemia after autotransplantation for lymphoma: a multi-center case-control study. | Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DW. | Blood 101:2015-2023 |
| 2003 | A comparison of allogeneic and autologous bone marrow transplant for lymphoblastic lymphoma. | Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ. | Blood 101:2476-2482 |
| 2003 | Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. | van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, Freytes CO, Gibson J, Horowitz MM, Inwards DJ, Marks DI, Martino R, Maziarz RT, Molina A, Pavlovsky S, Pecora A, Schouten HC, Shea TC, Lazarus HM, Rizzo JD, Vose JM. | Blood 102:3521-3529 |
| 2003 | Performance of a new clinical grading system for chronic graft-versus-host disease: A multi-center study. | Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin J, Weisdorf DJ, Martin PJ, Vogelsang GB. | Blood 102:802-809 |
| 2003 | Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. | Peters C, Steward CG on behalf of the NMDP, IBMTR and the Working Party on Inborn Errors of the EBMT. | Bone Marrow Transplant 31:229-329 |
| 2003 | (Review) Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know? | Loberiza FR, Serna DS, Horowitz MM, Rizzo JD. | Bone Marrow Transplant 31:417-421 |
| 2003 | Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. | Krishnamurti L, Abel S, Maiers M, Flesch S. | Bone Marrow Transplant 31:547-550 |
| 2003 | Autologous stem cell transplantation in multiple myeloma patients <60 versus ≥ 60 years of age. | Reece DE, Bredeson C, Perez WS, Jagannath S, Zhang MJ, Ballen KK, Elfenbein GJ, Freytes CO, Gale RP, Gertz MA, Gibson J, Giralt SA, Keating A, Kyle RA, Maharaj D, Marcellus D, McCarthy PL, Milone GA, Nimer SD, Pavlovsky S, To LB, Weisdorf DJ, Wiernik PH, Wingard JR, Vesole DH. | Bone Marrow Transplant 32:1135-1143 |
| 2003 | Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer. | Rizzo JD, Williams S, Wu JT, Pecora A, Lazarus HM, Bolwell B, Fields KK, Gale RP, Elfenbein G, Horowitz MM, Antman K. | Bone Marrow Transplant 32:151-155 |
| 2003 | IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. | Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang M-J, Miller JS. | Bone Marrow Transplant 32:177-186 |
| 2003 | Outcome of autologous transplantation for mantle cell lymphoma (MCL): a study by the EBMT and ABMTR Registries following pathology review. | Vandenberghe E, de Ruiz Elvira C, Loberiza FR, Conde E, López-Guillermo A, Gisselbrecht C, Guilhot F, Vose JM, van Besien K, Rizzo JD, Weisenberger DD, Horowitz MM, Isaacson P, Goldstone A, Lazarus HM, Schmitz N. | Br J Haematol 120:793-800 |
| 2003 | Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. | Ringden O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS, Gale RP, Hale GA, Litzow MR, Martino R, Russell JA, Tiberghien P, Urbano-Ispizua A, Horowitz MM. | Br J Haematol 121:874-885 |
| 2003 | MICA, HLA-B Haplotype variation in five population groups of sub-Saharan African ancestry. | Tian W, Boggs DA, Uko G, Essiet A, Inyama M, Banjoko B, Adewole T, Ding WZ, Mohensi M, Chen DF, Palmer LJ, Fraser PA. | Genes and Immunity 4: 500-505 |
| 2003 | MHC class II genes in HCV viral clearance of hepatitis C infected Hispanic patients. | Azocar J, Clavijo O, Yunis E. | Hum Immunol 64(1): 99-102 |
| 2003 | Syngeneic hematopoietic stem cell transplantation for non-Hodgkin’s lymphoma: a comparison with allogeneic and autologous transplantation. | Bierman PJ, Sweetenham JW, Loberiza FR, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz MM, Goldstone A, Ballen KK, Bashey A, Bitran JD, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gale RP, Herzig RH, Lister J, Martino R, Miller AM, Milone G, Parker AN, Schenkein DP, Slavin S, Zhang MJ. | J Clin Oncol 21:3744-3753 |
| 2003 | Trends in survival rates after allogeneic hematopoietic stem cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. | Serna DS, Lee SJ, Zhang MJ, Baker KS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr. | J Clin Oncol 21:3754-3760 |
| 2003 | Unrelated donor stem cell transplantation: The role of the National Marrow Donor Program. | Karanes C, Confer D, Walker T, Askren A, Keller C. | Oncol 17:8 |
| 2003 | Survival Analysis: Techniques for Censored and Truncated Data. | Klein JP, Moeschberger ML. | In: Survival Analysis: Techniques for Censored and Truncated Data 2nd Edition |
| 2003 | Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers. | Hurley CK, Fernandez-Vina M, Setterholm M. | Tissue Antigens 61: 415-424 |
| 2003 | Identification of novel HLA class I alleles using single allele sequencing. | Lebedeva TV, Huang A, Janzen M, Lau M, Yu N. | Tissue Antigens 62(5): 433-5 |
| 2003 | New HLA haplotype frequency reference standards: High resolution and large sample typing of HLA-DR-DQ haplotypes in a sample of European Americans. | Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Fernández-Viña M. | Tissue Antigens 62: 1-12 |
| 2003 | Use of a neural network to assign serologic specificities to HLA-A, -B and -DRB1 allelic products. | Maiers M, Schreuder GMT, Fernández-Viña M, Lau M, Marsh S, Noreen H, Setterholm M, Hurley C. | Tissue Antigens 62: 1-29 |
| 2003 | Factors associated with ambivalence about bone marrow donation among newly recruited unrelated potential donors. | Switzer G, Myaskovsky L, Goycoolea J, Dew MA, King R, Confer D. | Transplantation 75(9): 1517-1523 |
2002
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2002 | Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. | Weisdorf D, Bishop M, Dharan B, Bolwell B, Cahn JY, Cairo M, Giralt S, Klein JP, Lazarus H, Litzow M, Marks D, McCarthy P, Miller C, Milone G, Russell J, Schultz KR, Sierra J, Wiernik P, Keating A, Loberiza FR, Kollman C, Horowitz MM. | Biol Blood Marrow Transplant 8:213-220 |
| 2002 | Autologous stem cell transplantation for small cell lung cancer. | Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM. | Biol Blood Marrow Transplant 8:273-280 |
| 2002 | Review article - conference synopsis: hematopoietic stem cell therapy in autoimmune diseases, October 2001. | Bredeson C, Forman SJ, Horowitz M, Openshaw H, Pavletic S, Wulffraat N. | Biol Blood Marrow Transplant 8:407-411 |
| 2002 | Cox proportional hazards regression models for survival data in cancer research. | Zhang MJ. | In: Biostatistical Applications in Cancer Research pp. 59-70 |
| 2002 | HLA-DR15 (DR2) is over-represented in myelodysplastic syndrome and aplastic anemia, and predicts a response to immunosuppression in myelodysplastic syndrome. | Saunthararajah Y, Nakamura R, Nam J, Robyn J, Loberiza FR, Maciejewski J, Simonis T, Molldrem J, Young N, Barrett AJ. | Blood 100:1570-1574 |
| 2002 | Bone Marrow Transplantation for HLA-Identical Siblings as Treatment for Myelodysplasia. | Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Marks DI, Canals C, Boogaerts MA, Goldman JM, Champlin RE, Keating A, Weisdorf DJ, Horowitz MM. | Blood 100:1997-2004 |
| 2002 | Severity of chronic graft-vs-host disease: association with treatment-related mortality and relapse. | Lee SJ, Klein JP, Barrett AJ, Ringdén O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socié G, Verdonck LF, Weisdorf DJ, Horowitz MM. | Blood 100:406-414 |
| 2002 | Allogenic bone marrow transplantation for chronic myelogenous leukemia: Comparative analysis of unrelated versus matched sibling donor transplantation. | Weisdorf D, Anasetti C, Antin JH, Kernan N, Kollman C, Snyder D, Petersdorf E, Nelson G, McGlave P. | Blood 99(6): 1971-1977 |
| 2002 | Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. | Castro-Malaspina H, Harris RE, Gajewski J, Ramsay N, Collins R, Dharan B, King R, Deeg HJ. | Blood 99(6):1943-1951 |
| 2002 | Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. | Bunin N, Carston M, Wall D, Adams R, Casper J, Kamani N, King R. | Blood 99(9): 3151-3157 |
| 2002 | The effect of tolerance to non-inherited maternal antigens (NIMA) on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or HLA-haploidentical sibling. | van Rood JJ, Loberiza FR, Jr., Zhang MJ, Oudshoorn M, Claas F, Cairo MS, Champlin RE, Gale RP, Ringdén O, Hows JM, Horowitz MM. | Blood 99:1572-1577 |
| 2002 | Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic luekaemia. | Smith FO, King R, Nelson G, Wagner JE, Robertson KA, Sanders JE, Bunin N, Emanuel PD, Davies SM. | Br J Haematol 116(3): 716-724 |
| 2002 | Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning regimens for acute myelogenous leukemia in first remission. | Litzow MR, Pérez WS, Klein JP, Bolwell BJ, Camitta B, Copelan EA, Gale RP, Giralt S, Keating A, Lazarus HM, Marks DI, McCarthy PL, Miller CB, Milone G, Prentice HG, Russell JA, Schultz KR, Trigg ME, Weisdorf DJ, Horowitz MM. | Br J Haematol 119:1115-1124 |
| 2002 | Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis. Oral mucositis patient provider advisory board. | Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T, Fuchs HJ, Haskins MN, Horowitz MM, Martin PJ, McGuire DB, Mullane K, Oster G. | Cancer Invest 20:1-8 |
| 2002 | Survival Analysis Methods In Cancer Studies. | Klein JP. | In: Cancer Statistics pp. 37-58 |
| 2002 | Association of depressive syndrome and early deaths among patients following stem cell transplantation for malignant diseases. | Loberiza FR, Jr., Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ. | J Clin Oncol 20:2118-2126 |
| 2002 | High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. | Berry DA, Broadwater G, Klein JP, Antman K, Aisner J, Bitran J, Costanza M, Freytes CO, Stadtmauer E, Gale RP, Henderson IC, Lazarus HM, McCarthy PL, Jr., Norton L, Parnes H, Pecora A, Perry MC, Rowlings PA, Spitzer G, Horowitz MM. | J Clin Oncol 20:743-750 |
| 2002 | An additive-multiplicative Cox-Aalen regression model. | Scheike TH, Zhang MJ. | Scand J Stat 29, 75-88 |
| 2002 | Multistate models for bone marrow transplantation studies. | Klein JP, Shu Y. | Stat Methods Med Res 11:117-139 |
| 2002 | HLA class I typing of volunteers for a bone marrow registry: QC analysis by DNA-based methodology identifies serological typing discrepancies in the assignment of HLA-A and B antigens. | Gourley I, Kearns J, McKeen M, Birkos S, Brown M, Kamoun M. | Tissue Antigens 59: 211-215 |
| 2002 | Racial and ethnic composition of volunteer cord blood donors: Comparison with volunteer unrelated marrow donors. | Ballen K, Hicks J, Dharan B, Ambruso D, Anderson K, Bianco C, Bemiller L, Dickey W, Lottenberg, R, O'Neill M, Popovsky M, Skerrett D, Sniecinski I, Wingard J. | Transfusion 42(10): 1279-1284 |
2001
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2001 | Allogeneic stem cell transplantation in patients with Hodgkin’s disease who relapse after autologous transplantation. | Freytes CO, Loberiza FR, Tsai TW, van Besien K, Reece DE, Phillips G, Bierman PJ, Vesole DH, Milone G, Pavlovsky S, Vose JM, Lazarus HM, Horowitz MM. | In: Autologous Blood & Marrow Transplantation X: Proceedings of the Tenth International Symposium. pp. 534-544 |
| 2001 | Transplantation therapy for adults with acute lymphoblastic leukemia: comparative analysis of autologous and unrelated donor bone marrow transplantation. | Weisdorf D, Dharan B, Horowitz M. | In: Autologous Blood & Marrow Transplantation X: Proceedings of the Tenth International Symposium. pp. 380-384 |
| 2001 | Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation. | Deeg JH, Amylon MD, Harris RE, Collins R, Beatty PG, Feig S, Ramsay N, Territo M, Khan SP, Pamphilon D, Leis JF, Burdach S, Anasetti C, Hackman R, Storer B, Mueller B. | Biol Blood Marrow Transplant 7: 208-215 |
| 2001 | Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: Strong graft versus leukemia effect and risk factors determining outcome. | Cornelissen JJ, Carston M, Kollman C, King R, Dekker AW, Löwenberg, Anasetti C. | Blood 97: 1572-1577 |
| 2001 | Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome by donor type: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. | Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringdén O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM. | Blood 97:1598-1603 |
| 2001 | Donor characteristics as risk factors for recipient outcome following unrelated bone marrow transplant: The effect of donor age. | Kollman C, Howe CWS, Anasetti C, Antin JA, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, Ratanatharathorn V, Weisdorf D, Confer DL. | Blood 98: 2043-2051 |
| 2001 | Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for CML: The U.S. National Marrow Donor Program experience. | Petersdorf EW, Kollman C, Hurley CK, Dupont B, Nademanee A, Begovich A, Weisdorf D, McGlave P. | Blood 98: 2922-2929 |
| 2001 | The effect of pretransplant interferon therapy on the outcome of unrelated donor stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase. | Lee SJ, Klein JP, Anasetti C, Antin JH, Loberiza FR, Jr., Bolwell BJ, LeMaistre CF, Litzow MR, Marks D, Waller EK, Matlack M, Giralt S, Horowitz MM. | Blood 98:3205-3211 |
| 2001 | NMDP Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently? | Switzer GE, Goycoolea JM, Dew MA, Graeff EC, Hegland J. | Bone Marrow Transplant 27: 917-923 |
| 2001 | Autotransplants for Hodgkin’s disease in first relapse or second remission: a report from the Autologous Blood and Marrow Transplant registry (ABMTR). | Lazarus HM, Loberiza FR, Jr., Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes C, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM. | Bone Marrow Transplant 27:387-396 |
| 2001 | Non-HLA barriers to unrelated donor stem cell transplantation. | Kollman C, Weis T, Switzer GE, Halet M, Kitajima D, Hegland J, Confer DL. | Bone Marrow Transplant 27:581-587 |
| 2001 | Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. | Anderlini P, Rizzo JD, Nugent ML, Schmitz NC, Champlin RE, Horowitz MM. | Bone Marrow Transplant 27:689-692 |
| 2001 | Statistical methods for the analysis and presentation of the results of bone marrow transplants: Part 2: Regression Modeling. | Klein JP, Rizzo JD, Zhang MJ, Keiding N. | Bone Marrow Transplant 28:1001-1011 |
| 2001 | Statistical methods for the analysis and presentation of the results of bone marrow transplants: Part 1: Unadjusted analysis. | Klein JP, Rizzo JD, Zhang MJ, Keiding N. | Bone Marrow Transplant 28:909-915 |
| 2001 | Recommendations for assessment and definitions of response and relapse in CML: A report from the Chronic Leukemia Working Committee of the IBMTR. | Giralt SA, Goldman J, Anasetti C, Cervantes F, Champlin R, Cross N, Hochhaus A, Klein JP, Papadopoulos E, Sobocinski K, Weisdorf D, Horowitz M on behalf of the Chronic Leukemia Working Committee of the IBMTR. | In: Chronic Myeloid Leukaemia - Biology and Treatment pp. 357-368 |
| 2001 | The effect of graft purging with 4-hydroperoxy-cyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia (AML). | Miller CB, Rowlings PA, Zhang MJ, Keating A, Jones RJ, Piantadosi S, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM. | Exp Hematol 29:1336-1346 |
| 2001 | Oral Mucositis and the clinical and economic outcomes of blood and marrow transplantation. | Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FKL, Horowitz MM. | J Clin Oncol 19:2201-2205 |
| 2001 | Autologous transplantation for diffuse aggressive non-Hodgkin’s lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry (ABMTR). | Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO, Pavlovsky S, Keating A, Yanes B, van Besien K, Armitage JO, Horowitz MM and others of the ABMTR Lymphoma Working Committee. | J Clin Oncol 19:406-413 |
| 2001 | Confidence bands for the difference of two survival curves under proportional hazards model. | Zhang MJ, Klein JP. | Lifetime Data Analysis 7:243-254 |
| 2001 | Transplant Registries: guiding clinical decisions and improving outcomes. | Horowitz MM, Loberiza FR, Bredeson CN, Rizzo JD, Nugent ML. | Oncol 15:649-659 |
| 2001 | Multistate models and outcome prediction in bone marrow transplantation. | Keiding N, Klein JP, Horowitz MM. | Stat Med 20:1871-1885 |
| 2001 | Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology. | Noreen HJ, Yu N, Hurley CK, Ohashi M, Baisch J, Endres R, Fernández-Viña M, Heine U, Hsu S, Kamoun M, Mitsuishi Y, Monos D, Perlee L, Rodriguez-Marino S, Smith A, Yang SY, Shipp K, Weis T, Howard A, Kollman C, Hegland J, Setterholm M. | Tissue Antigens 57(3) :221-229 |
| 2001 | Non-conservative substitutions distinguish previously uncharacterized HLA-A molecules. | Hickman H, Cavett J, Ellexson-Turner M, Sparkman J, Bennett T, Turner S, Sidebottom D, Trachtenberg E, Confer D, Hildebrand W. | Tissue Antigens 57: 95-102 |
| 2001 | The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and –DQ antigens. | Hurley CK, Schreuder GMT, Marsh SGE, Setterholm M et al. | Tissue Antigens 58(2):109-40 |
| 2001 | Three new DP alleles identified in a study of 800 unrelated bone marrow donor-recipient pairs. | Grams S, Wu J, Noreen HJ, Mangaccat J, Cognato MA, Johnson S, Segall M, Williams TM, Begovich AB. | Tissue Antigens 58: 272-275 |
2000
| Year | Title | Authors | Publication |
|---|---|---|---|
| 2000 | High dose chemotherapy and autologous hematopoietic stem cell transplantation for ovarian carcinoma in North America: a report from the Autologous Blood and Marrow Transplant Registry. | Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM. | Ann Int Med 133:504-515 |
| 2000 | Treatment of Relapsed Leukemia and EBV-Lymphoproliferativ Disorders after Unrelated Donor Bone Marrow Transplantation with Unrelated Donor Leukocyte Infusions. | Porter DL, Collins RH Jr, Hardy C, Kernan N, Giralt S, Flowers M, Casper JT, Drobyski W, Leahey A, Parker P, Mick R, Bate-Boyle B, King R, Antin JH. | Blood 95(4): 1214-1221 |
| 2000 | Unrelated donor marrow transplantation for chronic myelogenous leukemia: Nine years experience of the National Marrow Donor Program. | McGlave P, Shu X, Wen W, Anasetti C, Nademanee A, Champlin R, Antin JH, Kernan N, King R, Weisdorf DJ. | Blood 95(4): 2219-2225 |
| 2000 | Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. | Barrett AJ, Ringdén O, Zhang MJ, Bashey A, Cahn JY, Cairo MS, Gale RP, Gratwohl A, Locatelli F, Martino R, Schultz KR, Tiberghien P and the GVHD/GVL Working Committee of the International Bone Marrow Transplant Registry. | Blood 95:3323-3327 |
| 2000 | Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. | Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef MEHM, Gratwohl A, on behalf of the IBMTR Histocompatibility & Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). | Blood 95:3702-3709 |
| 2000 | T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. | Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O’Reilly RJ, Ringdén O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM. | Blood 95:3996-4003 |
| 2000 | Effect of short-term interferon therapy on the outcome of HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the International Bone Marrow Transplant Registry. | Giralt S, Szydlo R, Goldman JM, Veum JS, Biggs JC, Herzig RH, Klein JP, McGlave PB, Schiller G, Gale RP, Rowlings PA, Horowitz MM. | Blood 95:410-415 |
| 2000 | Engraftment and survival after unrelated donor bone marrow transplantation: A Report from the National Marrow Donor Program (NMDP). | Davies SM, Kollman C, Anasetti C, Antin JH, Gajewski J, Casper JT, Nademanee A, Noreen H, King R, Confer D, Kernan NA. | Blood 96: 4096-4102 |
| 2000 | Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. | Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger S, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM. | Blood 96:1254-1258 |
| 2000 | Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes account of patients who relapse and are restored to complete remission. | Craddock C, Szydlo RA, Klein JP, Dazzi F, Olavarria E, van Rhee EF, Pocock C, Cwynarski K, Apperley JF, Goldman JM. | Blood 96:86-90 |
| 2000 | The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: Analysis of 1,259 National Marrow Donor Program donor-recipient pairs. | Hurley CK, Baxter-Lowe LA, Begovich A, Fernández-Viña M, Noreen H, Schmeckpeper B, Awdeh Z, Chopek M, Salazar M, Williams TM, Yunis E, Kitajima D, Shipp K, Splett J, Winden T, Kollman C, Johnson D, Ng J, Hartzman RJ, Hegland J. | Bone Marrow Transplant 25: 385-393 |
| 2000 | Donor leukocyte infusions in acute lymphocytic leukemia. | Collins R, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W, Barrett AJ, Horowitz MM, Parker P. | Bone Marrow Transplant 26:511-516 |
| 2000 | Summary curves for patients transplanted for chronic myeloid leukemia salvaged by a donor lymphocyte infusion: the current leukemia free survival curve. | Klein JP, Keiding N, Shu Y, Szydlo RM, Goldman JM. | Br J Haematol 109:148-152 |
| 2000 | Statistical analysis. | Klein JP. | In: Clinical Bone Marrow and Stem Cell Transplantation: A Reference Textbook, Second Edition pp. 1415-1422 |
| 2000 | Regression models for survival data. | Johnson RA, Klein JP. | In: Handbook of Statistics pp. 161-191 |
| 2000 | Hematopoietic stem cell transplantation for severe autoimmune disease: know thyself. | Burt RK, Rowlings PA, Traynor A. | In: Hematopoietic Stem Cell Therapy pp. 203-215 |
| 2000 | Bone marrow transplantation using unrelated donors. | Horowitz MM, Howe CWS. | In: High Dose Cancer Therapy: Pharmacology, Hematopoietins and Stem Cells, 3rd Edition pp. 221-242 |
| 2000 | Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. | Beatty PG, Boucher KM, Mori M, Milford EL. | Hum Immunol 61(8): 834-840 |
| 2000 | Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. | Davies SM, Ramsay NKC, Klein JP, Weisdorf DJ, Bolwell B, Cahn J-Y, Camitta BM, Gale RP, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, Milone GA, Neudorf S, Perez WS, Powles RL, Prentice HG, Schiller G, Socié G, Vowels M, Wiley J, Yeager A, Horowitz MM. | J Clin Oncol 18:340-347 |
| 2000 | New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. | Socié G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, Sullivan KM, Rowlings PA, Kingma DW, Banks PM, Travis WD, Witherspoon RP, Sanders J, Jaffe ES, Horowitz MM. | J Clin Oncol 18:348-357 |
| 2000 | Graft versus host disease in children who have received cord blood or bone marrow transplant from an HLA-identical sibling. | Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E and other members of the Eurocord and the IBMTR Working Committee on Alternative Donor and Stem Cell Sources. | N Engl J Med 342:1846-1854 |
| 2000 | Maintaining updated DNA-based HLA assignments in the National Marrow Donor Program Bone Marrow Registry. | Maiers M, Hurley CK, Perlee L, Fernández-Viña M, Baisch J, Cook D, Fraser P, Heine U, Hsu S, Leffell MS, Mauer D, Noreen H, Tang T, Trucco M, Yang SY, Yu N, Hartzman RJ, Setterholm M, Winden T, Shepherd D, Hegland J. | Reviews in Immunogen 2: 449-460 |
| 2000 | Current status of allogeneic bone marrow transplantation in acquired aplastic anemia. | Horowitz MM. | Semin Hematol 37:30-42 |
| 2000 | Estimation of current leukemia-free survival following donor lymphocyte infusion therapy for patients with leukemia who relapse after allografting: application of a multistate model. | Klein JP, Szydlo RA, Craddock C, Goldman JM. | Stat Med 19:3005-3016 |
| 2000 | Large-scale DNA-based typing of HLA-A and HLA-B at low resolution is highly accurate, specific, and reliable. | Hurley CK, Maiers M, Ng J, Wagage D, Hegland J, Baisch J, Endres R, Fernández-Viña M, Heine U, Hsu S, Kamoun M, Mitsuishi Y, Monos D, Noreen H, Perlee L, Rodriguez-Marino S, Smith A, Stastny P, Trucco M, Yang SY, Yu N, Holsten R, Hartzman RJ, Setterholm M. | Tissue Antigens 55: 352-358 |
| 2000 | Going back to the roots: Effective utilization of HLA typing information for bone marrow registries requires full knowledge of the DNA sequences of the oligonucleotide reagents used in the testing. | Helmberg W, Hegland J, Hurley CK, Maiers M, Marsh SG, Muller C, Rozemuller EH. | Tissue Antigens 56(1): 99-102 |
| 2000 | HLA-B*0811: Another example of a single point substitution of the HLA-B-0801 allele. | Magira E, Beznik-Cizman B, Monos D. | Tissue Antigens 56(5): 457-459 |
| 2000 | HLA-B*1559: A hybrid allele including exon 2 of HLA-B35 and exon 3 of HLA-B15 and serologically typed as B35. | Magira E, Beznik-Cizman B, Monos D. | Tissue Antigens 56(5): 460-462 |
| 2000 | Peripheral blood progenitor cells for HPC transplants involving unrelated donors. | Stroncek DF, Confer DL, Leitman S. | Transfusion 40: 731-741 |
1999
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1999 | Alternative donor bone marrow transplantation for severe acquired aplastic anemia. | Hows J, Stone JV, Camitta B. | In: Aplastic Anemia - Pathophysiology and Treatment pp. 258-274 |
| 1999 | Tacrolimus versus cyclosporine immunosuppression: results in advanced stage disease patients with comparison to historical controls. | Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR. | Biol Blood Marrow Transplant 5:180-186 |
| 1999 | Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. | Deeg HJ, Seidel K, Casper J, Anasetti C, Davies S, Gajewski JL, Territo M, Ramsay N, Harris RE, Castro-Malaspina H, Collins R, Champlin R, Schoch G, King R, Howe CWS. | Biol Blood Marrow Transplant 5 (4): 243-252 |
| 1999 | Comparing reference charts. | Scheike TH, Zhang MJ, Juul. | Biometrical Journal 41:679-687 |
| 1999 | Modeling random effects for censored data by a multivariate normal regression model. | Klein JP, Pelz C, Zhang MJ. | Biometrics 55:497-506 |
| 1999 | Risk of lymphoproliferative disorders following bone marrow transplantation: A multi-institutional study. | Curtis RE, Travis LB, Rowlings PA, Socié G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ. | Blood 94:2208-2216 |
| 1999 | Special report: Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: Report from The World Marrow Donor Association. | Hurley CK, Wade JA, Oudshoorn M, Middleton D, KuKuruga D, Navarrete C, Christiansen F, Hegland J, Ren E-C, Andersen I, Cleaver SA, Brautbar C, Raffoux C. | Bone Marrow Transplant 24: 119-121 |
| 1999 | Factors associated with attrition from a National Bone Marrow Registry. | Switzer GE, Dew MA, Stukas AA, Goycoolea JM, Hegland J, Simmons RG. | Bone Marrow Transplant 24: 313-319 |
| 1999 | Autotransplants in thirteen men with breast cancer. | McCarthy PL, Jr., Hurd DD, Rowlings PA, Murphy SC, Antman KH, Armitage JO, Cirenza E, Crump M, Doroshow J, Freytes CO, Gale RP, Kalman LA, Lazarus HM, Vaughan WP, Weinberger B, Wiemann MC, Horowitz MM. | Bone Marrow Transplant 24:365-368 |
| 1999 | Bone marrow transplants for paroxysmal nocturnal hemoglobinuria. | Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA, Passweg JR, Nugent ML, Luzzato L, Horowitz MM, Gordon-Smith EC. | Br J Haematol 104:392-396 |
| 1999 | Graft-versus-leukemia effects of bone marrow transplantation. | Horowitz MM, Truitt RL. | In: Clinical Bone Marrow and Blood Stem Cell Transplantation. A Reference Textbook, Second Edition pp. 1327-1338 |
| 1999 | International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry. | Sobocinski KA, Rowlings PA, Zhang MJ, Klein JP, Horowitz MM. | In: Clinical Bone Marrow and Blood Stem Cell Transplantation. A Reference Textbook, Second Edition pp. 1423-1444 |
| 1999 | Allogeneic hematopoietic stem cell transplantation. | Rowlings PA. | In: Ex Vivo Cell Therapy pp. 85-97 |
| 1999 | Uses and growth of hematopoietic cell transplantation. | Horowitz MM. | In: Hematopoietic Cell Transplantation, Vol II pp. 12-18 |
| 1999 | A special report: Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. | Hurley CK, Wade JA, Oudshoorn M, Middleton D, KuKuruga D, Navarrete C, Christiansen F, Hegland J, Ren E-C, Andersen I, Cleaver SA, Brautbar C, Raffoux C on behalf of the Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Assoc. | Hum Immunol 60:347-360 |
| 1999 | Increased incidence of Hodgkin disease following allogeneic bone marrow transplant. | Rowlings PA, Curtis RE, Passweg JR, Deeg HJ, Socié G, Travis LB, Kingma DW, Jaffe ES, Sobocinski KA, Horowitz MM. | J Clin Oncol 17:3122-3127 |
| 1999 | Autotransplants for Hodgkin disease in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry. | Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM. | J Clin Oncol 17:534-545 |
| 1999 | Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-b1. | Zeller J, Panoskaltisis-Mortari A, Murphy WJ, Ruscetti F, Narula S, Roncarolo M, Blazar B. | J Immunol 163: 3684-3691 |
| 1999 | Determining when the survival rates of two treatments are the same based on a censored data regression. | Klein JP, Zhang MJ. | J Stat Plan Infer 78:243-254 |
| 1999 | Factors correlated with progression-free survival after high-dose therapy and hematopoietic stem cell transplantation for metastatic breast cancer. | Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr., Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM. | JAMA 282:1335-1343 |
| 1999 | Long-term survival and late deaths after allogeneic bone marrow transplantation. | Socié G, Veum-Stone J, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn J-Y, Passweg JR, Rowlings PA, Schouten HC, Kolb H-J, Klein JP on behalf of the Late Effects Working Committee of the International Bone Marrow Transplant Registry. | New Engl J Med 341:14-21 |
| 1999 | Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects. | Andersen PK, Klein JP, Zhang MJ. | Stat Med 18:1489-1500 |
| 1999 | Modeling covariate adjusted mortality relative to a standard population. | Andersen PK, Horowitz MM, Klein JP, Socié G, Stone JV, Zhang MJ. | Statist Med 18:1529-1540 |
| 1999 | Four new DP alleles identified in a study of 500 unrelated bone marrow donor-recipient pairs. | Steiner LL, Wu J, Noreen HJ, Moehlenkamp C, Cavalli A, Davidson M, Johnson S, Winden T, Segall M, Begovich AB, Williams TM. | Tissue Antigens 53: 201-206 |
| 1999 | A special report: Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors, on behalf of the Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. | Hurley CK, Wade JA, Oudshoorn M, Middleton D, KuKuruga D, Navarrete C, Christiansen F, Hegland J, Ren E-C, Andersen I, Cleaver SA, Brautbar C, Raffoux C. | Tissue Antigens 53: 394-406 |
| 1999 | The HLA dictionary 1999: A summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and –DQ antigens. | Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ. | Tissue Antigens 54: 409-437 |
| 1999 | Current Status of Blood and Marrow Transplantation. | Horowitz MM. | In: Transplantation in Hematology and Oncology pp. 11-21 |
1998
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1998 | Bone marrow transplantation. | Horowitz MM. | In: 1998 Yearbook of Hematology pp. 319-377 |
| 1998 | Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia: A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry. | Sullivan KM, Anasetti C, Horowitz MM, Rowlings PA, Petersdorf EW, Martin PJ, Clift RA, Walters MC, Gooley T, Sierra J, Anderson JE, Flowers MED, Nash RA, Sanders JE, Appelbaum FR, Storb R, Hansen JA. | Ann New York Acad Sci 850:312-324 |
| 1998 | Cumulative regression function tests for regression models for longitudinal data. | Scheike TH, Zhang MJ. | Ann Stats 26:1328-1355 |
| 1998 | Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. | Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb H-J, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM and the German CML Study Group. | Blood 91:1810-1819 |
| 1998 | Allogeneic bone marrow transplantation for low grade lymphoma. | van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, Chaekal OK, Gale RP, Klein JP, Lazarus HM, McCarthy PL Jr, Ramaekers JM, Reiffers J, Phillips GL, Schattenberg AVMB, Verdonck LF, Vose JM, Horowitz MM. | Blood 92:1832-1836 |
| 1998 | Response to Letter to the Editor regarding IBMTR severity index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br J Haematol 97:855-864, 1997. (Response to Letter to Editor). | Rowlings PA, Klein JP, Gale RP, Horowitz MM. | Blood 92:3479-3481 |
| 1998 | Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft versus host disease and graft rejection. | Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM, Barrett AJ, Waldmann H. | Blood 92:4581-4590 |
| 1998 | Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. | Passweg JR, Rowlings PA, Atkinson KA, Barrett AJ, Gale RP, Gratwohl A, Jacobsen N, Klein JP, Ljungman P, Russell JA, Schaefer UW, Sobocinski KA, Vossen JM, Zhang MJ, Horowitz MM. | Bone Marrow Transplant 21:1231-1238 |
| 1998 | Graft versus leukemia effects in T-lineage and B-lineage acute lymphoblastic leukemia. | Passweg JR, Tiberghien P, Cahn J-Y, Vowels MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah N, Klein JP, Marks DI, Ramsay NKC, Rowlings PA, Weisdorf DJ, Zhang MJ, Barrett AJ. | Bone Marrow Transplant 21:153-158 |
| 1998 | Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: What Do We Know? | Waters TM, Bennett C, Pajeau TS, Sobocinski KA, Klein JP, Rowlings PA, Horowitz MM. | Bone Marrow Transplant 21:641-650 |
| 1998 | Chemotherapy versus HLA-identical sibling transplants for adults with acute lymphoblastic leukemia in first remission. | Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, Ohno R, Rowlings PA, Sobocinski KA, Tanimoto M, Tomonaga M, Weisdorf DJ, Horowitz MM. | Bone Marrow Transplant 22:253-257 |
| 1998 | Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. | Blade J, Samson D, Reece D, Apperley J, Bjorkstrand B, Gahrton G, Gertz M, Giralt S, Jagannath S, Vesole D. | Br J Haematol 102:1115-1123 |
| 1998 | Bone Marrow Transplantation in the Older Patient. | Fields KK, Vesole DH, Rowlings PA, Horowitz MM, Elfenbein G. | In: Comprehensive Geriatric Oncology pp. 471-480 |
| 1998 | Exponential distribution. | Klein JP, Anderson PK, Keiding N. | In: Encyclopedia of Biostatistics, volume 2 pp. 1447-1448 |
| 1998 | Grouped survival times. | Zhang MJ. | In: Encyclopedia of Biostatistics, volume 2 pp. 1785-1790 |
| 1998 | Survival distributions and their characterizations. | Klein JP. | In: Encyclopedia of Biostatistics, volume 6 pp. 4466-4472 |
| 1998 | Tied survival times. | Zhang MJ. | In: Encyclopedia of Biostatistics, volume 6 pp. 4520-4522 |
| 1998 | Weibull distribution. | Klein JP, Anderson PK, Keiding N. | In: Encyclopedia of Biostatistics, volume 6 pp. 4734-4735 |
| 1998 | Related donor bone marrow transplantation for chronic myelogenous leukemia. | Passweg JR, Rowlings PA, Horowitz MM. | In: Hematology/Oncology Clinics of North America, Biology and Therapy of Chronic Myelogenous Leukemia Vol. 12 No. 1 pp. 81-92 |
| 1998 | Initial therapy for chronic myelogenous leukemia: playing the odds. Editorial. | Lee SJ, Anasetti C, Horowitz MM, Antin J. | J Clin Oncol 16:2897-2903 |
| 1998 | G-CSF-mobilized donor leukocyte infusions as immunotherapy in acute leukemia relapsing after allogeneic marrow transplantation. | Mandanas RA, Saez RA, Selby GB, Confer DL. | J Hematotherapy 7:449-456 |
| 1998 | Sequence based typing provides a new look at HLA-C diversity. | Turner S, Ellexson ME, Hickman HD, Sidebottom DA, Fernández-Viña M, Confer DL, Hildebrand WH. | J Immunol 161(3): 1406-1413 |
| 1998 | High-dose chemotherapy in metastatic breast cancer. (Letter to Editor). | Rowlings, PA. | Lancet 351:1733 |
| 1998 | Transfer of diabetes type 1 by bone-marrow transplantation. | Lampeter EF, McCann SR, Kolb H. | Lancet 351:568-69 |
| 1998 | A comparison of related and unrelated marrow donors. | Chang G, McGarigle C, Spitzer T, McAfee S, Harris F, Piercy K, Goetz MA, Antin J. | Psychosom Med 60: 163-167 |
1997
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1997 | Bone marrow transplantation for acute myelogenous leukemia. | Horowitz MM, Gale RP, Büchner T, Keating A, Rowlings PA, Sobocinski KA, Zhang MJ, Klein JP. | In: Acute Leukemias VI: Prognostic Factors and Treatment Strategies pp. 807-809 |
| 1997 | Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: A decision analysis. | Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH. | Ann Int Med 127:1080-1088 |
| 1997 | Results of transplanting bone marrow from genetically-identical twins into patients with aplastic anemia. | Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP, Kolb HJ, Stevens DA, Horowitz MM, Gale RP. | Ann Intern Med 126:116-122 |
| 1997 | Safeguarding the administration of high-dose chemotherapy: A national practice survey by the American Society for Blood and Marrow Transplantation. | Chen CS, Seidel K, Armitage JO, Fay JW, Appelbaum FR, Horowitz MM, Shpall EJ, Weiden PL, Antman KS, Champlin RE, Kersey JH, Sullivan KM. | Biol Blood Marrow Transplant 11: 331-340 |
| 1997 | Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. | Petersdorf EW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, Martin PJ, Hansen JA. | Blood 89(5): 1818-1823 |
| 1997 | Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. | Weisdorf DJ, Billett AL, Hannan P, Ritz J, Sallan SE, Steinbuch M, Ramsay NKC. | Blood 90(8): 2962-2968 |
| 1997 | Bone marrow transplantation for severe aplastic anemia: Has outcome improved? | Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, Speck B, Tichelli A, Zhang MJ, Horowitz MM, Bortin MM. | Blood 90:858-864 |
| 1997 | Donor work-up and transport of bone marrow - Recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA). | Cleaver SA, Warren P, Kern M, Hurley CK, Raffoux C, Keller J, Kiesel U, Koza V, Marry E, Mitterschiffthaler A, Nakamura M, Okah CT, Persson U, Radde-Stepaniak T, Ranson L, Raymond J, do Rosario Sancho M, Varla-Leftherioti M, Wiegand T, Winterhager JM, Woodfield DG. | Bone Marrow Transplant 20: 621-629 |
| 1997 | IBMTR severity index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. | Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM. | Br J Haematol 97:855-864 |
| 1997 | Survival of patients with chronic myelogenous leukemia relapsing after bone marrow transplantation: Comparison with patients receiving conventional chemotherapy. | Zhang MJ, Baccarani M, Gale RP, McGlave P, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O’Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM. | Br J Haematol 99:23-29 |
| 1997 | An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. | Horowitz MM, Rowlings PA. | In: Current Opinion in Hematology pp. 395-400 |
| 1997 | Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. | Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb H-J, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM. | J Clin Oncol 15:1767-1777 |
| 1997 | High-dose chemotherapy with autologous hematopoietic stem cell support for breast cancer in North America. | Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM. | J Clin Oncol 15:1870-1879 |
| 1997 | Solid cancers after bone marrow transplantation. | Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socié G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr. | New Engl J Med 336:897-904 |
| 1997 | Experience from the International Bone Marrow Transplant Registry and the National Marrow Donor Program with Bone Marrow Transplantation of Genetic Diseases. | Filipovich AH. | In: Proceedings of the Nobel symposium on Frontiers in Medicine: BMT for Genetic Diseases, COGENT IV pp. 75-79 |
| 1997 | The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates. | Keiding N, Andersen PK, Klein JP. | Stats in Med 16:215-224 |
| 1997 | Acquisition and use of DNA-based HLA typing data in bone marrow registries. | Hurley CK. | Tissue Antigens 49: 323-328 |
| 1997 | Six new DPB1 alleles identified in a study of 1,302 unrelated bone marrow donor-recipient pairs. | Noreen H, Steiner L, Davidson M, Johnson S, Segall M, Begovich AB. | Tissue Antigens 49: 512-516 |
| 1997 | Analysis of HLA-A and -B serologic typing of bone marrow registry donors using polymerase chain reaction with sequence-specific oligonucleotide probes and DNA sequencing. | Sintasath DM, Bei M, Steiner N, Ng J, Alosco S, Hegland JD, Hurley CK. | Tissue Antigens 50: 366-371 |
| 1997 | Accurate typing of HLA-A antigens and analysis of serological deficiencies. | Yu N, Ohashi M, Alosco S, Granja C, Salazar M, Hegland J, Yunis E. | Tissue Antigens 50: 380-386 |
| 1997 | The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1*/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. | Hurley CK, Schreuder GMT, Marsh SGE, Lau M, Middleton D, Noreen H. | Tissue Antigens 50: 401-418 |
| 1997 | HLA gene and haplotype frequencies in the north American population: The National Marrow Donor Program Donor Registry. | Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. | Transplant 64(7): 1017-1027 |
1996
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1996 | HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. | Michallet M, Archimbaud E, Bandini G, Rowlings PA, Deeg HJ, Gahrton G, Montserrat E, Rozman C, Gratwohl A, Gale RP, for the European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry. | Ann Intern Med 124:311-315 |
| 1996 | Autotransplant Activity 1989-1994. | Gale RP, Rowlings PA, Armitage JO. | In: Autologous Stem Cell Transplantation: Biological and Clinical Results in Malignancies |
| 1996 | Computer program to predict likelihood of finding an HLA-matched donor: Methodology, validation, and application. | Mori M, Graves M, Milford EL, Beatty PG. | Biol Blood Marrow Transplant 2: 134-144 |
| 1996 | Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler Syndrome. | Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, Henslee-Downey J, Trigg ME, Cowan MJ, Sanders J, Bunin N, Weinstein H, Lenarsky C, Falk P, Harris R, Bowen T, Williams TE, Grayson GH, Warkentin P, Sender L, Cool VA, Crittenden M, Packman S, Kaplan P, Lockman LA, Anderson J, Krivit W, Dusenbery K, Wagner J. | Blood 87(11): 4894-4902 |
| 1996 | Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. | Horowitz MM, Rowlings PA, Passweg JR. | Bone Marrow Transplant 17 (Suppl 3):S5-S6 |
| 1996 | Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. | Rozman C, Carreras E, Qian C, Gale RP, Bortin MM, Rowlings PA, Ash RC, Champlin RE, Henslee-Downey PJ, Herzig RH, Hinterberger W, Klein JP, Prentice HG, Reiffers J, Zwaan FE, Horowitz MM. | Bone Marrow Transplant 17:75-80 |
| 1996 | Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. | Passweg JR, Rowlings PA, Armitage JO, Gale RP, Pelz CJ, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM. | In: Clinical Transplants 1995 pp 117-127 |
| 1996 | Unrelated-Donor Marrow Transplants: The Experience of the National Marrow Donor Program. | Beatty P, Kollman C, Howe C. | Clinical Transplants 1995: 271-277 |
| 1996 | Bone marrow transplants from HLA-identical siblings in advanced Hodgkin’s disease. | Gajewski JL, Phillips GL, Sobocinski KA, Armitage JO, Gale RP, Champlin RE, Herzig RH, Hurd DD, Jagannath S, Klein JP, Lazarus HM, McCarthy PL Jr, Pavlovsky S, Petersen FB, Rowlings PA, Russell JA, Silver SM, Vose JM, Wiernik PH, Bortin MM, Horowitz MM. | J Clin Oncol 14:572-578 |
| 1996 | Chemotherapy versus transplants for acute myelogenous leukemia in second remission. | Gale RP, Horowitz MM, Rees JKH, Gray RG, Oken MM, Estey EH, Kim KM, Zhang MJ, Ash RC, Atkinson K, Champlin RE, Dicke KA, Gajewski JL, Goldman JM, Helbig W, Henslee-Downey PJ, Hinterberger W, Jacobsen N, Keating A, Klein JP, Marmont AM, Prentice HG, Reiffers J, Rimm AA, Rowlings PA, Sobocinski KA, Speck B, Wingard JR, Bortin MM. | Leukemia 10:13-19 |
| 1996 | HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. | Gale RP, Büchner T, Zhang MJ, Heinecke A, Champlin RE, Dicke KA, Gluckman E, Good RA, Gratwohl A, Herzig RH, Keating A, Klein JP, Marmont AM, Prentice HG, Rowlings PA, Sobocinski KA, Speck B, Weiner RS, Horowitz MM. | Leukemia 10:1687-1691 |
| 1996 | Fitting Cox's Proportional Hazards Model using Grouped Survival Data. | McKeague IW and Zhang MJ. | In: Life Data: Models in Reliability and Survival Analysis pp. 227-232 |
| 1996 | Statistical challenges in comparing chemotherapy and bone marrow transplantation as a treatment for leukemia. | Klein JP, Zhang MJ. | In: Lifetime Data: Models in Reliability and Survival Analysis pp. 175-185 |
| 1996 | Modeling multistate survival illustrated in bone marrow transplantation. | Klein JP, Qian C. | Proc Biometrics Sect of Amer Stat Soc 93-102 |
| 1996 | Toxicity of blood and marrow transplantation: Data from the IBMTR and ABMTR. | Rowlings PA. | Stem Cells 14:470-472 |
| 1996 | Large-scale DRB and DQB1 oligonucleotide typing for the NMDP Registry: Progress report from year 2. | Ng J, Hurley CK, Carter C, Baxter-Lowe LA, Bing D, Chopek M, Hegland J, Lee TD, Li TC, Hsu S, KuKuruga D, Mason JM, Monos D, Noreen H, Rosner G, Schmeckpeper B, Dupont B, Hartzman RJ. | Tissue Antigens 47: 21-26 |
| 1996 | Identification of a new allele, DRB1*1204, during routine PCR-SSOP typing of National Marrow Donor Program volunteers. | Rodriguez SG, Crevling CL, Steiner N, Hurley CK. | Tissue Antigens 48: 221-223 |
| 1996 | Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. | Wagner JL, Deeg HJ, Seidel K, Anasetti C, Doney K, Sanders J, Sullivan KM, Storb R. | Transplant 61(1): 54-61 |
| 1996 | Current status of allogeneic and autologous blood and marrow transplantation: Report from the IBMTR and ABMTR - North America. | Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM. | In: Yearbook of Cell and Tissue Transplantation pp 19-34 |
1995
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1995 | Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. | Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Löffler H, Sobocinski KA, Thiel E, Weisdorf DJ, for the Acute Lymphoblastic Leukemia Working Committee. | Ann Intern Med 123:428-431 |
| 1995 | Estimation of the variance in a Cox’s regression model’s with shared gamma frailties. | Andersen PK, Klein JP, Knudsen KM, Palacios R. | Biometrics 53:1475-1484 |
| 1995 | Bone marrow transplantation for Fanconi anemia. | Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W, Good RA, Gordon-Smith EC, Harris RE, Klein JP, Ortega JJ, Pasquini R, Ramsay NKC, Speck B, Vowels MR, Zhang MJ, Gale RP. | Blood 86:2856-2862 |
| 1995 | Bone marrow transplantation for Diamond-Blackfan anemia. | Mugishima H, Gale RP, Rowlings PA, Horowitz MM, Marmont AM, McCann SR, Sobocinski KA, Bortin MM. | Bone Marrow Transplant 15:55-58 |
| 1995 | Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. | Gale RP, Horowitz MM, Weiner RS, Ash RC, Atkinson K, Babu R, Dicke KA, Klein JP, Lowenberg B, Reiffers J, Rimm AA, Rowlings PA, Sandberg AA, Sobocinski KA, Veum-Stone J, Bortin MM. | Bone Marrow Transplant 16:203-208 |
| 1995 | Allogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells. | Barquinero J, Witherspoon R, Sanders J, Horowitz MM, Montuoro A, Patton DF, Bacigalupo A, Abecasis MM, Miale T, Rozman C, Bryant E, Storb R. | Br J Haematol 90:595-601 |
| 1995 | Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry. | Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM. | In: Clinical Transplants 1994 pp 87-98 |
| 1995 | Bone-marrow transplantation for leukaemia [letter]. | Gale RP, Goldman JM, Horowitz MM, Silberman G, Crosse MG, Peterson EA, Weston RC. | Lancet 345:1235 |
| 1995 | Bone marrow transplantation for severe aplastic anemia: A report from the International Bone Marrow Transplant Registry. | Horowitz MM, Passweg JR, Sobocinski KA, Nugent ML, Klein JP. | In: Ontogeny of hematopoiesis. Aplastic anemia. Vol. 235, pp 313-317 |
| 1995 | Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. | Beatty PG, Mori M, Milford E. | Transplant 60(8): 778-783 |
1994
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1994 | IBMTR analysis of results of bone marrow transplantation in acute leukemia. | IBMTR. | In: Acute Leukemias IV: Prognostic Factors pp. 681-685 |
| 1994 | The US National Marrow Donor Program. | Perkins HA, Hansen JH. | Am J Pediatr Hematol Oncol 16(1): 30-34 |
| 1994 | Identical-twin bone marrow transplants for leukemia. | Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringdén O, Stone JA, Bortin MM. | Ann Intern Med 120:646-652 |
| 1994 | Marrow transplants from HLA matched unrelated donors: An NMDP update and the Seattle experience. | Anasetti C, Howe CWS, Petersdorf EW, Martin PJ, Hansen JA. | Bone Marrow Transplant 13:693-695 |
| 1994 | 25th Anniversary of the first successful allogeneic bone marrow transplants. | Bortin MM, Bach FH, van Bekkum DW, Good RA, van Rood JJ. | Bone Marrow Transplant 14:211-212 |
| 1994 | Developing areas: T cell depletion of donor marrow. | Martin PJ, Horowitz MM. | In: Clinical Bone Marrow Transplant pp. 653-657 |
| 1994 | The International Bone Marrow Transplant Registry. | Sobocinski KA, Horowitz, MM, Rimm AA, Gale RP, Bortin MM. | In: Clinical Bone Marrow Transplant pp. 732-735 |
| 1994 | Graft-versus-leukemia effects of bone marrow transplantation. | Horowitz MM, Truitt RL. | In: Clinical Bone Marrow Transplantation pp 704-714 |
| 1994 | Cox regression in a Markov renewal model: An application to the analysis of bone marrow transplant data. | Dabrowska DM, Sun G-W, Horowitz MM. | J Amer Stat Assoc 89:867-877 |
| 1994 | Comparison of chemotherapy and bone marrow transplants using two independent clinical databases. | Messerer D, Neiss A, Horowitz MM, Hoelzer D, Gale RP. | J Clin Epidemiol 47:1119-1126 |
| 1994 | Bone Marrow Transplantation-1994: A report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. | Sobocinski KA, Horowitz MM, Rowlings PA, Zhang MJ, Nugent ML, Passweg JR, Armitage JO, Gale RP, Bortin MM. | J Hematoth 3:95-102 |
| 1994 | Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. | Silberman G, Crosse MG, Peterson EA, Weston RC, Horowitz MM, Appelbaum FR, Cheson BD. | N Engl J Med 331:1063-1067 |
| 1994 | Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. | Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA, Rimm AA, Klein JP, Shuster JJ, Sobocinski KA, Gale RP. | N Engl J Med 331:1253-1258 |
| 1994 | The changing activities of a regional marrow donor program. | Stroncek D, Strand R, Hofkes C, McCullough J. | Transfusion 34(1): 58-62 |
1993
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1993 | Results of bone marrow transplants from human leukocyte antigen-identical sibling donors for treatment of childhood leukemias: A report from the International Bone Marrow Transplant Registry. | Horowitz MM, Bortin MM. | Am J Pediatr Hematol Oncol 15:56-64 |
| 1993 | Unrelated donor marrow transplantation for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program. | McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, Kernan N. | Blood 8(2): 543-550 |
| 1993 | Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program. | Stroncek DF, Holland PV, Bartsch G, Bixby T, Simmons RG, Antin JH, et al. | Blood 81(7): 1940-1946 |
| 1993 | Psychosocial effects of unrelated bone marrow donation: Experiences of the National Marrow Donor Program. | Butterworth VA, Simmons RG, Schimmel M. | Blood 81(7): 1947-1959 |
| 1993 | Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? | Ringdén O, Horowitz MM, Sondel P, Gale RP, Biggs JC, Champlin RE, Deeg H-J, Dicke KA, Masaoka T, Powles RL, Rimm AA, Rozman C, Sobocinski KA, Speck B, Zwaan FE, Bortin MM. | Blood 81:1094-1101 |
| 1993 | Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. | Goldman JM, Szydlo R, Horowitz MM, Gale RP, Ash RC, Atkinson K, Dicke KA, Gluckman E, Herzig RH, Marmont A, Masaoka T, McGlave PB, Messner H, O'Reilly RJ, Reiffers J, Rimm AA, Speck B, Veum-Stone JA, Wingard JR, Zwaan FE, Bortin MM, for the Advisory Committee of the IBMTR. | Blood 82:2235-2238 |
| 1993 | Anti-pan T-lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors. | Krance R, Heslop HE, Mahmoud H, Ribeiro R, Douglass E, Hurwitz C, Santana V, Kun L, Horowitz MM, Brenner MK. | Bone Marrow Transplant 11:33-36 |
| 1993 | Predicting results of alternative donor transplants for thalassemia using a chronic myelogenous leukemia model. | Gale RP, Horowitz MM. | Bone Marrow Transplant 12(Suppl 1):82-83 |
| 1993 | 1993 Progress Report from the International Bone Marrow Transplant Registry. | Bortin MM, Horowitz MM, Rowlings PA, Rimm AA, Sobocinski KA, Zhang MJ, Gale RP. | Bone Marrow Transplant 12:97-104 |
| 1993 | Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. | Rowlings PA, Horowitz MM, Armitage JO, Gale RP, Sobocinski KA, Zhang MJ, Bortin MM. | In: Clinical Transplants pp. 101-108 |
| 1993 | Outcome after allogeneic bone marrow transplant for leukemia in older adults. | Ringdén O, Horowitz MM, Gale RP, Biggs JC, Gajewski J, Rimm AA, Speck B, Veum-Stone JA, de Witte T, Bortin MM. | JAMA 270:57-60 |
| 1993 | The origins and development of the National Marrow Donor Program. | Zumwalt Admiral ER, Howe CWS. | Leukemia 7(7): 1122 |
| 1993 | Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. | Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. | N Engl J Med 328: 593-602 |
| 1993 | The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: Results of a National Marrow Donor Program involving multiple centers. | Mickelson EM, Bartsch GE, Hansen JA, Dupont B. | Tissue Antigens 42: 465-572 |
| 1993 | Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable. | Ng J, Hurley CK, Baxter-Lowe LA, Chopek M, Coppo PA, Hegland J, KuKuruga D, Monos G, Rosner G, Schmeckpeper B, Yang SY, Dupont B, Hartzman RJ. | Tissue Antigens 42: 473-479 |
| 1993 | Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporine compared to either agent alone for prevention of graft-versus-host disease. | Ringdén O, for the Advisory Committee of the International Bone Marrow Transplant Registry. | Transplant Proc 25 (1 PT 2):1241-1242 |
1992
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1992 | Increasing utilization of allogeneic bone marrow transplantation, III: Results of the 1988-1990 survey. | Bortin MM, Horowitz MM, Rimm AA. | Ann Intern Med 116:505-512 |
| 1992 | Allogeneic bone marrow transplantation. | Horowitz MM, Bortin MM, Gale RP. | In: Atlas of Organ Transplantation pp. 11.1-11.21 |
| 1992 | Current status of allogeneic bone marrow transplantation. | Sobocinski KA, Horowitz MM, Rimm AA, Bortin MM. | Biomed & Pharmacother 46:57-69 |
| 1992 | Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. | Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM, Masaoka T, Ramsay NKC, Rimm AA, Rozman C, Sobocinski KA, Speck B, Bortin MM. | Blood 79:269-275 |
| 1992 | Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? | Horowitz MM, Przepiorka D, Champlin RE, Gale RP, Gratwohl A, Herzig RH, Prentice HG, Rimm AA, Ringdén O, Bortin MM. | Blood 79:2771-2774 |
| 1992 | Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. | Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE and Bortin MM. | Blood 79:3067-3070 |
| 1992 | Bone marrow transplants may cure persons with acute leukemia never achieving remission with chemotherapy. | Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringdén O, Rozman C, Sobocinski KA, Veum JA, Bortin MM. | Blood 80:1090-1093 |
| 1992 | Progress report from the International Bone Marrow Transplant Registry. | Bortin MM, Horowitz MM, Rimm AA. | Bone Marrow Transplant 10:113-122 |
| 1992 | What determines who develops graft-versus-host disease: the graft or the host (or both)? (Editorial). | Gale RP, Horowitz MM, Butturini A, Barrett AJ, Kolb H-J. | Bone Marrow Transplant 10:99-102 |
| 1992 | Second HLA-identical sibling transplants for leukemia recurrence. | Mrsic M, Horowitz MM, Atkinson K, Biggs JC, Champlin RE, Ehninger G, Gajewski JL, Gale RP, Herzig RH, Prentice HG, Rozman C, Sobocinski KA, Speck B, Bortin MM. | Bone Marrow Transplant 9:269-275 |
| 1992 | Therapy decisions in leukemia. | Atkinson KA, Horowitz MM, Sobocinski KA, Rimm AA, Bortin MM, Gale RP. | Bone Marrow Transplant 9:5-10 |
| 1992 | The role of registries in evaluating the results of bone marrow transplantation. | Horowitz MM, Bortin MM. | In: Bone Marrow Transplantation in Practice pp. 367-377 |
| 1992 | Graft-versus-leukemia effects of bone marrow transplantation. | Horowitz MM. | In: Cambridge Medical Reviews: Haematological Oncology, Vol. II pp. 1-14 |
| 1992 | Graft- versus-leukemia effect of allogeneic bone marrow transplantation: Clinical and experimental aspects of late leukemia relapse. | Truitt RL, Horowitz MM, Atasoylu AA, Drobyski WR, Johnson LeFever AV. | In: Cellular Immune Mechanisms and Tumor Dormancy |
| 1992 | Report from the International Bone Marrow Transplant Registry. | Rowlings PA, Horowitz MM, Rimm AA, Sobocinski KA, Zhang MJ, Bortin MM. | In: Clinical Transplants 1992 pp. 83-90 |
| 1992 | Changing trends in bone marrow transplantation for leukemia in the 1980's. | Bortin MM, Horowitz MM, Gale RP, Barrett AJ, Champlin RE, Dicke KA, Gluckman E, Kolb H-J, Marmont AM, Mrsic M, Sobocinski KA, Weiner RS, Rimm AA. | JAMA 268:607-612 |
| 1992 | Progress in allogeneic bone marrow transplantation for acute lymphoblastic leukemia in the 1980's: A Report from the IBMTR. | Bortin MM, Barrett AJ, Horowitz MM, Gale RP, Sobocinski KA, Rimm AA. | Leukemia 6 (Suppl 2):196-197 |
1991
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1991 | Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. | Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G, Hiddemann W, Kolb H-J, Löffler H, Marmont AM, Maschmeyer G, Rimm AA, Rozman C, Sobocinski KA, Speck B, Theil E, Weisdorf DJ, Zwaan FE, Bortin MM. | Ann Intern Med 115:13-18 |
| 1991 | T-cell depletion of HLA-identical transplants in leukemia. | Marmont AM, Horowitz MM, Gale RP, Sobocinski KA, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringdén O, Speck B, Weiner RS, Bortin MM. | Blood 78:2120-2130 |
| 1991 | Bone marrow transplantation from related donors other than HLA-identical siblings: Effect of T-cell depletion. | Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC, Henslee-Downey PJ, Kolb HJ, Lowenberg B, Masaoka T, McGlave PB, Rimm AA, Ringdén O, van Rood JJ, Sondel PM, Vowels MR, Bortin MM. | Bone Marrow Transplant 7:443-452 |
| 1991 | Autotransplants in acute leukemia. | Gale RP, Horowitz MM, Butturini A. | Br J Haematol 78:135-137 |
| 1991 | Current status of allogeneic bone marrow transplantation. | Horowitz MM, Bortin MM. | In: Clinical Transplants, 1990 pp. 41-52 |
| 1991 | What does total body irradiation do in bone marrow transplants for leukemia? | Gale RP, Butturini A, Bortin MM. | Int J Radiat Oncol Biol Phys 20:631-634 |
| 1991 | The use of a clinical data registry to evaluate medical technologies: Experience from the International Bone Marrow Transplant Registry. | Rimm AA, Barr JT, Horowitz MM, Bortin MM. | Int J Technol Assess 7:182-193 |
| 1991 | Graft-versus-leukemia. | Horowitz MM, Gale RP. | In: New Strategies in Bone Marrow Transplantation pp. 275-280 |
| 1991 | Evaluating new therapy for acute myeloid leukemia. | Keating A, Horowitz MM. | Semin Hematol 28 (Suppl 4):70-71 |
| 1991 | Does more intensive therapy increase cures in acute leukemia? | Gale RP, Butturini A, Horowitz MM. | Semin Hematol 28 (Suppl 4):93-94 |
| 1991 | Progress in bone marrow transplantation for leukemia: A preliminary report from the Advisory Committee of the International Bone Marrow Transplant Registry. | Bortin MM, Horowitz MM, Mrsic M, Rimm AA, Sobocinski KA. | Transplant Proc 23:61-62 |
1990
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1990 | Autotransplants in leukemia: Approaches to prevent leukemia relapse. | Gale RP, Horowitz MM, Butturini A. | In: Autologous Bone Marrow Transplantation IV pp. 255-257 |
| 1990 | Risk factors for chronic graft-vs-host disease after HLA-identical sibling bone marrow transplantation. | Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb H-J, Rimm AA, Ringdén O, Rozman C, Sobocinski KA, Zwaan FE, Bortin MM. | Blood 75:2459-2464 |
| 1990 | Graft-versus-leukemia reactions after bone marrow transplantation. | Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey JH, Kolb H‑J, Rimm AA, Ringdén O, Rozman C, Speck B, Truitt RL, Zwann FE, Bortin MM. | Blood 75:555-562 |
| 1990 | IBMTR analysis of bone marrow transplants in acute leukemia. | Gale RP, Horowitz M, Bortin M. | Bone Marrow Transplant 4:83-85 |
| 1990 | How best to analyze new strategies in bone marrow transplantation (Editorial). | Gale RP, Horowitz MM. | Bone Marrow Transplant 6:357-359 |
| 1990 | Current status of allogeneic bone marrow transplantation: A report from the International Bone Marrow Transplant Registry. | Bortin MM, Horowitz MM. | In: Clinical Transplants, 1989 pp. 127-140 |
| 1990 | Allogeneic bone marrow transplantation: A review. | Horowitz MM, Bortin MM, Gale RP. | Doga Turkish J Med Science 14:513-541 |
| 1990 | Graft-vs-leukemia effects in clinical bone marrow transplantation. | Weiden PL, Horowitz MM. | In: Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment pp. 691-708 |
| 1990 | HLA class I and II antigen phenotypes of North American Indians from Minnesota: Implications for marrow transplants using unrelated donors. | Stroncek DF, Strand RD, Noreen HJ, Kline WE, McGlave PB, Bartsch GE, McCullough J. | Transfusion 30(6): 521-527 |
1989
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1989 | Bone marrow transplantation for thalassemia - a preliminary report from the International Bone Marrow Transplant Registry. | Barrett AJ, Lucarelli G, Gale RP, Sobocinski KA, Horowitz M, Bortin MM. | In: Advances and Controversies in Thalassemia Therapy: Bone Marrow Transplantation and Other Approaches pp. 173-185 |
| 1989 | Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. | Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C, Speck B, Bortin MM. | Blood 73:606-613 |
| 1989 | Marrow transplantation for acute lymphoblastic leukemia: Factors affecting relapses and survival. | Barrett AJ, Horowitz MM, Gale RP, Biggs JC, Camitta BM, Dicke KA, Gluckman E, Good RA, Herzig RH, Lee MB, Marmont AM, Masaoka T, Ramsay NKC, Rimm AA, Speck B, Zwaan FE, Bortin MM. | Blood 74:862-871 |
| 1989 | Factors influencing the risk of acute and chronic graft-versus-host disease in humans: A preliminary report from the IBMTR. | Bortin MM, Atkinson K, van Bekkum DW, Biggs JC, Dicke KA, Gale RP, Gluckman E, Good RA, Hoffmann RG, Horowitz MM, Kay HEM, Kersey JH, Marmont AM, Masaoka T, Jacobsen N, Kolb H-J, Parkman R, Ringdén O, Rozman C, van Rood JJ, Zwaan FE. | Bone Marrow Transplant 4 (Suppl 1):222-224 |
| 1989 | Bone marrow transplantation for acute lymphoblastic leukaemia in first and second remission. | Barrett AJ, Horowitz MM, McCarthy DM, Kanfer E, Bortin MM. | Bone Marrow Transplant 4 (Suppl 1):247-254 |
| 1989 | Report from the International Bone Marrow Transplant Registry. | Advisory Comm of the IBMTR. | Bone Marrow Transplant 4:221-228 |
| 1989 | Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. | Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM. | Bone Marrow Transplant 4:247-254 |
| 1989 | Temporal relationship between the major complications of bone marrow transplantation for leukemia. | Bortin MM, Ringdén O, Horowitz MM, Rozman C, Weiner RS, Rimm AA. | Bone Marrow Transplant 4:339-344 |
| 1989 | Proposals for standardized reporting of results of bone marrow transplantation for leukaemia. | Clift R, Goldman JM, Gratwohl A, Horowitz MM. | Bone Marrow Transplant 4:445-448 |
| 1989 | Risk factors for interstitial pneumonia following bone marrow transplantation for severe aplastic anemia. | Weiner RS, Horowitz MM, Gale RP, Dicke KA, van Bekkum DW, Masaoka T, Ramsay N, Rimm AA, Rozman C, Bortin MM. | Br J Haematol 71:535-543 |
| 1989 | Transplant or chemotherapy in acute myelogenous leukaemia. | Gale RP, Horowitz MM, Biggs JC, Blume KA, Herzig RH, Kersey JH, Marmont AM, Masaoka T, Speck B, Rimm AA, Weiner RS, Zwaan FE, Bortin MM. | Lancet 1:1119-1122 |
| 1989 | Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukemia. | Horowitz MM, Gale RP, Barrett AJ, Biggs JC, Camitta BM, Dicke KA, Gluckman E, Good RA, Herzig RH, Lee MB, Marmont AM, Masaoka T, Ramsay NKC, Rimm AA, Speck B, Zwaan FE, Bortin MM. | Lancet 1:535-537 |
| 1989 | The National Marrow Donor Program: How it works, accomplishments to date. | McCullough J, Hansen J, Perkins H, Stroncek D, Bartsch G. | Oncology 3(2): 63-72 |
| 1989 | Graft-versus-leukemia reactions in humans. | Ringdén O, Horowitz MM. | Transplant Proc 21:2989-2992 |
| 1989 | Increasing utilization of bone marrow transplantation, II: Results of 1985 - 1987 survey. | Bortin MM, Rimm AA. | Transplantation 48:453-458 |
1988
1987
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1987 | HLA associations with leukemia. | Bortin MM, D'Amaro J, Bach FH, Rimm AA, van Rood JJ. | Blood 70:227-232 |
| 1987 | Graft-versus-leukemia following bone marrow transplantation. | Butturini A, Bortin MM, Gale RP. | Bone Marrow Transplant 2:233-242 |
| 1987 | Risk factors for acute graft-vs-host disease. | Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, Good RA, Hoffmann RG, Kay HEM, Kersey JH, Marmont A, Masaoka T, Rimm AA, van Rood JJ, Zwaan FE. | Br J Haematol 67:397-406 |
| 1987 | Graft-vs-leukemia following bone marrow transplantation: A model of immunotherapy in man. | Butturini A, Bortin MM, Seeger RC, Gale RP. | Cellular Immunotherapy of Cancer pp. 371-390 |
| 1987 | Current status of allogeneic bone marrow transplantation: A report from the International Bone Marrow Transplant Registry. | Bortin MM, Gale RP. | In: Clinical Transplants, 1986 pp. 17-28 |
| 1987 | Bone marrow transplantation: The difficulties ahead. | Bortin MM, Horowitz MM, Rimm AA. | In: Experimental Hematology Today - 1987 pp. 134-140 |
| 1987 | Which treatment for childhood acute lymphoblastic leukemia in second remission? | Butturini A, Rivera GK, Bortin MM, Gale RP. | Lancet 1:429-432 |
| 1987 | Bone-marrow transplantation in high-risk acute lymphoblastic leukemia in first and second remission. | Herzig RH, Bortin MM, Barrett AJ, Blume KG, Gluckman E, Horowitz MM, Jacobsen SJ, Marmont AM, Masaoka T, Prentice HG, Ramsay NKC, Rimm AA, Ringdén O, Speck B, Zwaan FE, Gale RP. | Lancet 1:786-789 |
| 1987 | Factors influencing the risk of acute graft-versus-host disease in man. | Bortin MM. | In: Recent Advances in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Volume 53 pp. 243-264 |
| 1987 | Interstitial pneumonia following bone marrow transplantation. | Weiner RS, for the Advisory Committee of the IBMTR. | In: Recent Advances in Bone Marrow Transplantation, UCLA Symposia on Molecular and Cellular Biology, New Series, Volume 53 pp. 507-523 |
| 1987 | Bone marrow transplantation for acute leukemia: A preliminary report from the International Bone Marrow Transplant Registry. | Champlin RE, for the Advisory Committee of the IBMTR. | Transplant Proc 19: 2626-2628 |
| 1987 | Current status of bone marrow transplantation for severe aplastic anemia: A preliminary report from the International Bone Marrow Transplant Registry (IBMTR). | Gluckman E, for the Advisory Committee of the IBMTR. | Transplant Proc 19:2597-2599 |
| 1987 | Bone marrow transplantation in leukemia using family donors other than HLA-identical siblings: A preliminary report from the International Bone Marrow Transplant Registry (IBMTR). | Bortin MM, for the Advisory Committee of the IBMTR. | Transplant Proc 19:2629-2631 |
| 1987 | Risk factors for interstitial pneumonitis following allogeneic bone marrow transplantation for severe aplastic anemia: A preliminary report. | Weiner RS, Dicke KA, for the Advisory Committee of the IBMTR. | Transplant Proc 19:2639-2642 |
| 1987 | Acute graft-vs-host disease following bone marrow transplantation in humans: Prognostic factors. | Bortin MM, for the Advisory Committee of the IBMTR. | Transplant Proc 19:2655-2657 |
1986
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1986 | Interstitial pneumonitis after bone marrow transplantation: Assessment of risk factors. | Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HEM, Hartz AJ, Kolb H-J, Rimm AA. | Ann Intern Med 104:168-175 |
| 1986 | Analysis of bone marrow transplantation data in man. | Gale RP. | Bone Marrow Transplant 1:3-9 |
| 1986 | Allogeneic bone marrow transplantation in leukemia patients. | Bortin MM. | Curr Prob Cancer 10:1-52 |
| 1986 | Risk factors for acute graft-versus-host disease in humans. | Bortin MM. | In: Experimental Hematology Today 1985: Selected Papers from the 14th Annual Meeting of the International Society for Experimental Hematology pp. 114-121 |
| 1986 | Increasing utilization of bone marrow transplantation. | Bortin MM, Rimm AA. | Transplantation 42:229-234 |
1985
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1985 | Report from the International Bone Marrow Transplant Registry, 1984. | Bortin MM for the Advisory Committee of the International Bone Marrow Transplant Registry. | Exp Hematol 13:709-714 |
| 1985 | Bone marrow transplantation in leukemia: International Bone Marrow Transplant Registry (IBMTR) data. | Gale RP, Bortin MM. | Int J Cell Cloning 5:236-237 |
| 1985 | Bone marrow transplantation for chronic myelogenous leukaemia. | Goldman JM, Bortin MM, Champlin RE, Herzig RH, McGlave PB, Messner HA, Rimm AA, Speck B, Weiner RS. | Lancet 2:1295 |
| 1985 | Risk factors associated with interstitial pneumonitis following allogeneic bone marrow transplantation for leukemia. | Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HEM, Kolb H-J, Hartz AJ, Rimm AA. | Transplant Proc 17:470-474 |
| 1985 | Association of HLA‑C antigens with acute leukemia: A report from the International Bone Marrow Transplant Registry. | Bortin MM, D'Amaro J, Bach FH, van Rood JJ, Rimm AA. | Transplant Proc 17:744-746 |
1984
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1984 | Report from the International Bone Marrow Transplant Registry (IBMTR), 1983. | Bortin MM. | Exp Hematol 12:199-204 |
| 1984 | Long-term survival after bone marrow transplantation: A 15-year follow-up report of a patient with Wiskott-Aldrich syndrome. | Meuwissen HJ, Bortin MM, Bach FH, Porter IH, Schreinmachers D, Harrison BA, Taft E. | J Pediatr 105:365-369 |
| 1984 | Allogeneic bone marrow transplantation for chronic myelogenous leukemia. | Speck B, Bortin MM, Champlin R, Goldman JM, Herzig RH, McGlave PB, Messner HA, Weiner RS, Rimm AA. | Lancet 1:665-668 |
| 1984 | HLA-C associations with acute leukemia. | D'Amaro JD, van Rood JJ, Bach FH, Rimm AA, Bortin MM. | Lancet 2:1176-1178 |
1983
1982
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1982 | Interstitial pneumonitis: Dose-rate vs total dose of radiation. | Bortin MM, Rimm AA. | Int J Radiat Oncol Biol Phys 8:1815-1816 |
| 1982 | Factors associated with interstitial pneumonitis after bone marrow-transplantation for acute leukemia. | Bortin MM, Kay HEM, Gale RP, Rimm AA. | Lancet 1:437-439 |
| 1982 | Bone marrow transplantation for acute leukaemia in first remission. | Gale RP, Kay HEM, Rimm AA, Bortin MM. | Lancet 2:1006-1009 |
1981
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1981 | Allogeneic bone marrow transplantation for l44 patients with severe aplastic anemia. | Bortin MM, Gale RP, Rimm AA. | JAMA 245:1132-1139 |
| 1981 | Treatment of 144 patients with severe aplastic anemia using immunosuppression and allogeneic marrow transplantation: A report from the International Bone Marrow Transplant Registry. | Bortin MM, Rimm AA. | Transplant Proc 8:227-229 |
1980
1979
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1979 | Factors influencing success and failure of human marrow transplantation: A review from the International Bone Marrow Transplant Registry. | Bortin MM, Rimm AA. | In: Experimental Hematology Today 1979 pp. 173-178 |
1978
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1978 | Bone marrow transplantation for acute myeloblastic leukemia. | Bortin MM, Rimm AA. | JAMA 240:1245-1252 |
1977
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1977 | Knochenmarktransplantation zar therapie schwerer panmyelopathien. | Niethammer D, Lohrmann HP, Bortin MM, Rimm AA. | Dtsch Artzblatt-Artzliche Mitteilungen 74:1127-1133 |
| 1977 | Severe combined immunodeficiency disease: Characterization of the disease and results of transplantation. | Bortin MM, Rimm AA. | JAMA 238:591-600 |
| 1977 | HLA antigens and severe combined immunodeficiency disease. | Rimm AA, Bortin MM. | Lancet 1:1361-1362 |
| 1977 | Bone marrow transplantation: A brief review of the history, current status and potential. | Bortin MM. | Northwest Community Hospital Med Bull 14: 855-859 |
| 1977 | Severe combined immunodeficiency disease: Characterization of the disease and results of transplantation. | Bortin MM, Rimm AA. | Transplant Proc 9:169-170 |
1976
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1976 | Summary analysis of marrow transplant data from the International Bone Marrow Transplant Registry. | Bortin MM, Rimm AA. | In: Human Bone Marrow Transplantation pp. 93-94 |
| 1976 | From histocompatible, allogeneic donors for aplastic anemia: A report from the ACS/NIH Bone Marrow Transplant Registry. | Bortin MM, Rimm AA, for the Advisory Committee of the Bone Marrow Transplant Registry. | JAMA 236:1131-1135 |
1975
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1975 | Report from the ACS/NIH Bone Marrow Transplant Registry. | Advisory Committee of the Bone Marrow Transplant Registry. | Exp Hematol 3:149-155 |
1973
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1973 | ACS/NIH Organ Transplant Registry: Third scientific report. | Bortin MM, Rimm AA, for the Advisory Committee to the Registry. | JAMA 226:1211-1216 |
1972
| Year | Title | Authors | Publication |
|---|---|---|---|
| 1972 | ACS/NIH Organ Transplant Registry: Second scientific report. | Bortin MM, Rimm AA, for the Advisory Committee to the Registry. | JAMA 221:1486-1491 |
